index,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,Ribosome,-0.7816519730636533,-3.697185018579151,0.0,0.0,0.0,90/148,7.21%,RPS27;RPL13A;RNA5S7;RNA5S17;RPS18;RNA5S6;RPL3;RPS5;RPL13;RPS15A;RPL36;RPL37A;RPS21;RPS19;RPSA;RPL18A;RPS3;RPLP2;RPS28;RPL10A;RPL23A;RPS6;RPL39;RNA5S5;RPS20;RPL10;RPLP0;RPL18;RNA5S15;RPL9;RPL32;RPS16;RPS14;RPL7A;RNA5S12;RPS10;RPL27A;RPS25;RPL30;RPL29;RPS17;RPL35;RPS4X;RPS15;RPL12;RPL37;RPL4;RNA5S3;RPS23;RPS29;RNA5S14;RNA5S2;RNA5S1;RNA5S13;RPS7;RPL14;RPL5;RPL27;RPL38;RPL41;RPS3A;RPS8;RPL24;RPL8;RPL19;RPS13;RNA5S4;RPLP1;RPL35A;RPS2;RPS10-NUDT3;RNA5S8;RPS27A;RPL11;RNA5S16;RPL17;RNA5S11;RPS12;RNA5S10;RPL22;RPS26;RPL6;RPS11;RPL23;RPL26;RPL15;RPL31;RPL7;RPL21;FAU
1,prerank,NOD-like receptor signaling pathway,0.6766253072305047,2.4039610376121736,0.0,0.0,0.0,60/143,13.93%,GBP5;GBP1;GBP4;STAT1;OAS3;STAT2;GBP2;OAS1;CASP5;IRF7;AIM2;OAS2;GBP3;IFI16;CYBB;NOD2;IRF9;CASP1;CCL2;RBCK1;P2RX7;RIPK2;MEFV;CARD16;CASP4;IL1B;TANK;GSDMD;TBK1;RNASEL;RNF31;TLR4;PKN2;NAMPT;TNF;XIAP;IFNAR2;NOD1;MAPK14;IFNAR1;CARD6;ANTXR2;RIPK1;ERBIN;NAIP;PRKCD;NLRC4;MYD88;NFKBIA;TXNIP;CTSB;NEK7;CHUK;TAB3;TNFAIP3;NLRP3;PANX1;CARD8;BIRC2;ITPR2
2,prerank,Influenza A,0.6748985839520867,2.3770874848675834,0.0,0.0,0.0,48/129,10.66%,RSAD2;STAT1;CXCL10;OAS3;STAT2;IFIH1;MX1;OAS1;PML;TNFSF10;IRF7;OAS2;FAS;ICAM1;JAK2;EIF2AK2;ADAR;TLR7;IRF9;CASP1;CCL2;MX2;TRIM25;CALCOCO2;IL1B;SOCS3;TBK1;RNASEL;CIITA;HLA-DMB;BAK1;TLR4;HLA-DRA;TNFRSF1A;TNF;HLA-DMA;IFNAR2;HLA-DQB1;IFNAR1;BID;HLA-DPA1;EP300;CREBBP;MYD88;IFNGR2;NFKBIA;HLA-DRB1;HLA-DRB5
3,prerank,Hepatitis C,0.6536018832869612,2.264900165702618,0.0,0.0,0.0,51/113,18.30%,RSAD2;STAT1;CXCL10;OAS3;STAT2;IFIT1;MX1;OAS1;IRF7;OAS2;FAS;EIF2AK2;IRF9;MX2;STAT3;SOCS3;TBK1;RNASEL;RB1;BAK1;TNFRSF1A;TNF;CFLAR;IFNAR2;SOS1;IFNAR1;PPP2R2A;RIPK1;BID;CDKN1A;PIAS1;LDLR;GSK3B;NFKBIA;GRB2;CHUK;APAF1;YWHAG;KRAS;TICAM1;YWHAB;PIK3CA;NFKB1;CASP8;PPP2CB;NRAS;PPP2CA;YWHAE;RAF1;SOS2;CASP3
4,prerank,Systemic lupus erythematosus,0.6813370636897195,2.235666012969584,0.0,0.0,0.0,37/75,16.14%,FCGR1A;H2BC18;C2;TRIM21;C1QB;H4C8;FCGR3B;FCGR2A;CD40;C1QC;HLA-DMB;H2BC4;HLA-DRA;FCGR3A;TNF;HLA-DMA;H3-3A;H2AC19;H2AC18;HLA-DQB1;H2BC21;HLA-DPA1;H2AC7;C1QA;H3C6;H3C4;H3-3B;HLA-DRB1;H2AC20;HLA-DRB5;H3-5;C1R;ACTN1;H4C5;CD86;SSB;HLA-DPB1
5,prerank,Osteoclast differentiation,0.6528311588029582,2.223567512834695,0.0,0.0,0.0,52/107,16.51%,FCGR1A;STAT1;STAT2;SOCS1;IRF9;NCF1;LCP2;LILRB1;FCGR2C;FCGR3B;IL1B;SOCS3;FCGR2A;LILRB3;LILRB4;LILRA6;FCGR3A;TNFRSF1A;TNF;FCGR2B;SIRPB1;JUNB;IFNAR2;RELB;MAPK14;CYLD;IFNAR1;NCF2;LILRB2;CSF1;LILRA1;IFNGR2;GAB2;NFKBIA;LILRB5;GRB2;TGFB1;FOSL2;SPI1;PPP3R1;CREB1;NFKB2;CHUK;RAC1;TGFBR1;TAB2;NCF4;SIRPA;PIK3CA;ITGB3;NFKB1;TGFBR2
6,prerank,Staphylococcus aureus infection,0.7216344795125457,2.2233137185338356,0.0,0.0,0.0,26/47,14.74%,FCGR1A;ICAM1;C2;C1QB;FCGR2C;FCGR3B;FCGR2A;C1QC;HLA-DMB;FPR2;HLA-DRA;FCGR3A;C3AR1;FCGR2B;HLA-DMA;HLA-DQB1;HLA-DPA1;PTAFR;C1QA;HLA-DRB1;HLA-DRB5;KRT23;C1R;FPR1;SELP;SELPLG
7,prerank,Phagosome,0.6429553847212361,2.220826730398132,0.0,0.0,0.0,61/114,20.42%,FCGR1A;TAP2;TAP1;CYBB;NCF1;VAMP3;MARCO;FCGR2C;FCGR3B;TLR2;FCGR2A;CD36;HLA-DMB;CTSS;ATP6V1B2;CTSL;TLR4;CLEC7A;HLA-DRA;FCGR3A;FCGR2B;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;RAB5A;LAMP2;ATP6V1G1;HLA-E;NCF2;TLR6;HLA-DPA1;ATP6V1A;HLA-B;RAB5C;HLA-DRB1;HLA-DRB5;HLA-F;STX12;HLA-A;ATP6V0D1;PIKFYVE;C1R;TCIRG1;RAC1;DYNC1LI1;STX7;NCF4;TUBA1A;TUBB1;HLA-DPB1;ITGB3;ACTB;RAB7A;ATP6V1C1;SEC22B;ATP6V1E1;LAMP1;RILP;HLA-DQA1;ATP6V1D
8,prerank,Tuberculosis,0.6313448851145546,2.2129688373555165,0.0,0.0,0.0,71/136,21.44%,FCGR1A;STAT1;JAK2;NOD2;RIPK2;TLR1;FCGR2C;FCGR3B;IL1B;TLR2;SRC;FCGR2A;CIITA;HLA-DMB;CTSS;TLR4;CLEC7A;HLA-DRA;FCGR3A;TNFRSF1A;TNF;FCGR2B;HLA-DMA;HLA-DQB1;MAPK14;CEBPB;RAB5A;LAMP2;BID;CD74;VDR;TLR6;HLA-DPA1;CAMK2D;EP300;CLEC4E;IL10RB;CREBBP;MYD88;IRAK2;FCER1G;SPHK1;IFNGR2;CASP10;RAB5C;HLA-DRB1;HLA-DRB5;TGFB1;PPP3R1;CREB1;RFX5;ATP6V0D1;BCL10;TCIRG1;APAF1;NFYA;HLA-DPB1;KSR1;NFKB1;CASP8;RAB7A;RAF1;CASP3;LAMP1;TRAF6;SYK;CALML4;HLA-DQA1;ATP6V0A1;CALM2;RHOA
9,prerank,Leishmaniasis,0.6911008212948372,2.2058651053849663,0.0,0.0,0.0,29/62,10.68%,FCGR1A;STAT1;JAK2;CYBB;NCF1;FCGR2C;FCGR3B;IL1B;PTGS2;TLR2;FCGR2A;HLA-DMB;TLR4;HLA-DRA;FCGR3A;TNF;HLA-DMA;HLA-DQB1;MAPK14;NCF2;HLA-DPA1;MYD88;IFNGR2;ITGA4;PTPN6;NFKBIA;HLA-DRB1;HLA-DRB5;TGFB1
10,prerank,Epstein-Barr virus infection,0.6167550399438475,2.2037052334146683,0.0,0.0,0.0,67/169,16.62%,STAT1;CXCL10;OAS3;STAT2;ISG15;OAS1;TAP2;TAP1;IRF7;OAS2;FAS;ICAM1;EIF2AK2;GADD45B;IRF9;STAT3;LYN;TAPBP;CIR1;TLR2;CD40;TBK1;HLA-DMB;RB1;BAK1;B2M;HLA-DRA;TNF;HLA-DMA;IFNAR2;HLA-G;HLA-C;HLA-DQB1;RELB;MAPK14;NFKBIE;IFNAR1;JAK3;RIPK1;HLA-E;BID;ENTPD1;HLA-DPA1;HLA-B;RBPJ;MYD88;CDKN1A;PDIA3;NFKBIA;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;NFKB2;CHUK;MDM2;TNFAIP3;APAF1;RAC1;TAB2;SAP30L;MAP2K4;PIK3CA;HLA-DPB1;NFKB1;POLK;CASP8
11,prerank,Measles,0.6121178520364357,2.0993466660153075,0.0,0.00010051867637006956,0.001,31/109,10.06%,STAT1;OAS3;STAT2;IFIH1;MX1;OAS1;IRF7;OAS2;FAS;EIF2AK2;ADAR;TLR7;IRF9;CD46;MX2;STAT3;IL1B;TLR2;TBK1;HSPA6;BAK1;TLR4;STAT5A;FCGR2B;IFNAR2;IFNAR1;JAK3;BID;MYD88;GSK3B;NFKBIA
12,prerank,Complement and coagulation cascades,0.7260992696379077,2.0835313819626218,0.0,9.214212000589708e-05,0.001,11/33,9.44%,SERPING1;C2;C1QB;CD46;CD59;C4BPA;PLAUR;C1QC;C3AR1;SERPINA1;C1QA
13,prerank,Toxoplasmosis,0.6176523018615954,2.0723281893845416,0.0,8.505426462082809e-05,0.001,42/84,20.33%,STAT1;SOCS1;JAK2;STAT3;TLR2;CD40;HSPA6;CIITA;HLA-DMB;TLR4;HLA-DRA;TNFRSF1A;TNF;XIAP;HLA-DMA;HLA-DQB1;MAPK14;LY96;HLA-DPA1;IL10RB;MYD88;LDLR;IFNGR2;NFKBIA;PPIF;HLA-DRB1;HLA-DRB5;TGFB1;CHUK;GNAI3;BIRC2;TAB2;HSPA8;HLA-DPB1;NFKB1;CASP8;PIK3CG;PIK3R5;CASP3;PDPK1;TRAF6;HLA-DQA1
14,prerank,Necroptosis,0.595085768848483,2.0652857661616144,0.0,7.897896000505465e-05,0.001,37/119,9.65%,STAT1;STAT2;TNFSF10;FAS;JAK2;EIF2AK2;CYBB;ZBP1;IRF9;CASP1;RBCK1;MLKL;CHMP5;STAT3;IL1B;RNF31;TICAM2;TLR4;STAT5A;TNFRSF1A;TNF;CFLAR;XIAP;IFNAR2;H2AC19;H2AC18;PLA2G4A;CYLD;IFNAR1;JAK3;RIPK1;BID;GLUL;CAMK2D;H2AC7;CHMP2B;IFNGR2
15,prerank,African trypanosomiasis,0.784007694785893,2.057187599126923,0.0,7.371369600471768e-05,0.001,9/21,8.54%,IDO1;APOL1;FAS;ICAM1;IL1B;F2RL1;TNF;GNAQ;MYD88
16,prerank,Pertussis,0.6484972896392224,2.0390830392184904,0.0,0.00013821318000884562,0.002,30/55,22.88%,SERPING1;IRF1;C2;C1QB;CASP1;C4BPA;CASP7;IL1B;C1QC;TICAM2;TLR4;TNF;NOD1;MAPK14;LY96;MYD88;C1QA;C1R;NLRP3;GNAI3;TICAM1;IRF8;NFKB1;CASP3;TRAF6;CALML4;CALM2;RHOA;MAPK1;PYCARD
17,prerank,Kaposi sarcoma-associated herpesvirus infection,0.5712214198451954,2.0189819250978247,0.0,0.00013008299294950176,0.002,68/153,20.22%,STAT1;STAT2;IRF7;FAS;ICAM1;JAK2;EIF2AK2;GNB4;IRF9;CCR1;MICB;STAT3;ATG3;LYN;GNG10;PTGS2;SRC;TBK1;TCF7L2;CLEC2B;RB1;BAK1;TNFRSF1A;ZFP36;IFNAR2;HLA-G;HLA-C;MAPK14;IFNAR1;HIF1A;HLA-E;HCK;BID;EP300;HLA-B;CREBBP;CDKN1A;MICA;GSK3B;NFKBIA;HLA-F;PREX1;HLA-A;PPP3R1;CREB1;CHUK;RAC1;ITPR2;CD86;KRAS;MAP2K4;TICAM1;PIK3CA;NFKB1;CASP8;GABARAP;PIK3CG;GNB1;NRAS;BECN1;PIK3R5;RAF1;CASP3;GNG5;SYK;CALML4;E2F2;GNB2
18,prerank,Toll-like receptor signaling pathway,0.6082845936283973,2.0043741321932083,0.0,0.0002457123200157256,0.004,33/77,16.62%,STAT1;CXCL10;IRF7;TLR7;TLR8;TLR1;IL1B;TLR2;CD40;TBK1;TICAM2;TLR4;TNF;IFNAR2;MAPK14;LY96;TLR5;IFNAR1;RIPK1;TLR6;MYD88;MAP3K8;NFKBIA;IRF5;CHUK;RAC1;CD86;TAB2;MAP2K4;TICAM1;PIK3CA;NFKB1;CASP8
19,prerank,Hepatitis B,0.5697845018274739,1.988083872820714,0.0,0.00029097511580809614,0.005,54/126,19.94%,STAT1;STAT2;IFIH1;IRF7;FAS;JAK2;STAT3;TLR2;SRC;TBK1;CREB5;RB1;TICAM2;TLR4;STAT5A;TNF;DDX3X;MAPK14;SOS1;IFNAR1;JAK3;PTK2B;BID;EP300;CREBBP;MYD88;CDKN1A;CASP10;NFKBIA;GRB2;TGFB1;CREB1;CHUK;APAF1;TGFBR1;TAB2;ATF2;KRAS;MAP2K4;TICAM1;YWHAB;PIK3CA;NFKB1;TGFBR2;CASP8;MAP3K1;NRAS;RAF1;SOS2;CASP3;CREB3L2;TRAF6;PRKCB;E2F2
20,prerank,TNF signaling pathway,0.5869681952474813,1.9805566950611893,0.0,0.00033171163202122956,0.006,40/89,17.32%,CXCL10;IRF1;FAS;ICAM1;NOD2;CCL2;MLKL;CASP7;BCL3;IL1B;SOCS3;PTGS2;IL15;CREB5;TNFRSF1A;TNF;CFLAR;JUNB;MAPK14;CEBPB;RIPK1;CSF1;CASP10;MAP3K8;NFKBIA;MAP3K5;CREB1;CHUK;TAB3;TNFAIP3;BIRC2;ITCH;TNFRSF1B;TAB2;ATF2;MAP2K4;PIK3CA;NFKB1;CASP8;RPS6KA5
21,prerank,JAK-STAT signaling pathway,0.5868024773460311,1.95136107941981,0.0,0.000684484320043807,0.013,30/84,10.31%,STAT1;STAT2;SOCS1;JAK2;IRF9;CSF2RB;IL13RA1;STAT3;IL15RA;SOCS3;IL15;STAT5A;IFNAR2;MCL1;IL12RB1;SOS1;IFNAR1;JAK3;IL6R;EP300;IL10RB;STAM2;CREBBP;CDKN1A;PIAS1;PIM1;IFNGR2;PTPN6;CSF3R;GRB2
22,prerank,C-type lectin receptor signaling pathway,0.5916831424058729,1.95056245927673,0.0,0.0006533713964054521,0.013,41/81,22.88%,STAT1;STAT2;IRF1;IRF9;CASP1;BCL3;IL1B;PTGS2;SRC;CLEC7A;PAK1;TNF;RELB;CLEC4D;MAPK14;CYLD;CLEC4E;PRKCD;FCER1G;NFKBIA;PPP3R1;NFKB2;CHUK;BCL10;MDM2;NLRP3;ITPR2;KRAS;PIK3CA;KSR1;NFKB1;CASP8;NRAS;RAF1;SYK;CALML4;CALM2;RHOA;PTPN11;MAPK1;PYCARD
23,prerank,Prolactin signaling pathway,0.6317956208810064,1.9435847861483737,0.0,0.0007691863930927061,0.016,20/46,18.34%,STAT1;SOCS1;IRF1;JAK2;STAT3;SOCS3;SRC;STAT5A;MAPK14;SOS1;GSK3B;GRB2;CISH;KRAS;PIK3CA;NFKB1;NRAS;RAF1;SOS2;SOCS4
24,prerank,Ribosome biogenesis in eukaryotes,-0.43382200526040754,-1.9353016965273173,0.0,0.008752276867030966,0.028,19/95,6.44%,RNA5S7;RNA5S17;RNA5S6;RNA5S5;RNA5S15;RNA5S12;RNA5S3;RNA5S14;RNA5S2;RNA5S1;RNA5S13;RNA5S4;FBL;RNA5S8;RNA5S16;RNA5S11;SNORD3A;RNA5S10;NOB1
25,prerank,Human cytomegalovirus infection,0.536396649380093,1.9201311954382572,0.0,0.0011517765000737137,0.025,73/171,20.50%,TAP2;TAP1;FAS;GNB4;CCR1;CCL2;STAT3;TAPBP;GNG10;IL1B;PTGS2;SRC;TBK1;CREB5;GNA13;RB1;BAK1;B2M;TNFRSF1A;TNF;AKAP13;CGAS;HLA-G;HLA-C;MAPK14;SOS1;SP1;PTK2B;IL6R;RIPK1;HLA-E;BID;GNAQ;HLA-B;IL10RB;CDKN1A;PDIA3;PTGER4;GSK3B;NFKBIA;GRB2;CXCR2;HLA-F;HLA-A;PPP3R1;CREB1;CHUK;MDM2;ROCK1;RAC1;GNAI3;ITPR2;CRK;ATF2;KRAS;PIK3CA;ITGB3;NFKB1;CASP8;ARHGEF11;ROCK2;GNB1;NRAS;RAF1;SOS2;CASP3;GNG5;CREB3L2;CALML4;PRKCB;E2F2;GNB2;ADCY3
26,prerank,Neutrophil extracellular trap formation,0.5496352210078986,1.9200675064544066,0.0,0.0011057054400707652,0.025,45/131,17.09%,FCGR1A;H2BC18;CYBB;TLR7;CASP1;TLR8;NCF1;CASP4;H4C8;FCGR3B;HDAC4;TLR2;SRC;FCGR2A;GSDMD;H2BC4;FPR2;TLR4;CLEC7A;FCGR3A;H3-3A;H2AC19;H2AC18;MAPK14;NCF2;H2BC21;H2AC7;H3C6;H3C4;H3-3B;PPIF;H2AC20;AQP9;CLCN4;H3-5;RAC1;H4C5;FPR1;SELP;SELPLG;NCF4;PIK3CA;ITGB3;NFKB1;ACTB
27,prerank,Antigen processing and presentation,0.5985957297477982,1.9160402861865222,0.0,0.0010631783077603512,0.025,35/66,16.14%,TAP2;TAP1;PSME2;PSME1;IFI30;TAPBP;HSPA6;CIITA;HLA-DMB;CTSS;CTSL;B2M;HLA-DRA;TNF;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;HLA-E;CD74;HLA-DPA1;HLA-B;PDIA3;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;CREB1;CTSB;RFX5;HSPA5;NFYA;HSP90AA1;HSPA8;HLA-DPB1
28,prerank,Lipid and atherosclerosis,0.531955750917596,1.9074306011107718,0.0,0.0011057054400707652,0.027,75/162,23.39%,TNFSF10;IRF7;FAS;ICAM1;JAK2;SOD2;CYBB;CASP1;CCL2;NCF1;STAT3;CASP7;LYN;IL1B;TLR2;SRC;TANK;CD36;CD40;TBK1;HSPA6;TICAM2;TLR4;TNFRSF1A;TNF;ATF6;MAPK14;LY96;NFE2L2;NCF2;BID;TLR6;CAMK2D;MYD88;ABCA1;LDLR;GSK3B;NFKBIA;MAP3K5;PPP3R1;CHUK;HSPA5;NLRP3;APAF1;RAC1;SELP;TAB2;NCF4;KRAS;MAP2K4;TICAM1;HSP90AA1;HSPA8;PIK3CA;CDC42;NFKB1;CASP8;ROCK2;NRAS;RAP1A;CASP3;TNFRSF10B;PDPK1;TRAF6;CALML4;VAV1;POU2F1;CALM2;RHOA;MAPK1;MIB1;TRAF3;PYCARD;HSP90B1;EIF2S1
29,prerank,RIG-I-like receptor signaling pathway,0.6135385305100672,1.9027898610925278,0.0,0.0011846844000758198,0.03,16/48,11.82%,CXCL10;ISG15;IFIH1;IRF7;DHX58;TRIM25;TANK;TBK1;TNF;DDX3X;MAPK14;CYLD;RIPK1;CASP10;NFKBIA;CHUK
30,prerank,Fc gamma R-mediated phagocytosis,0.5746910394251807,1.8943762727625713,0.0,0.0012200887614573959,0.032,35/75,20.13%,FCGR1A;LIMK2;NCF1;LYN;LIMK1;FCGR3B;MARCKS;FCGR2A;PTPRC;FCGR3A;PAK1;FCGR2B;PLA2G4A;GSN;ACTR2;HCK;WAS;PRKCD;VASP;ACTR3;ARPC5;SPHK1;GAB2;ASAP1;PIP5K1A;ARPC3;RAC1;CRK;PIK3CA;CDC42;RAF1;ARF6;SYK;PRKCB;INPPL1
31,prerank,Viral carcinogenesis,0.5286959464998816,1.890162472367208,0.0,0.0013268465280849183,0.036,76/158,24.42%,H2BC18;IRF7;EIF2AK2;POLB;IRF9;STAT3;LYN;H4C8;SP100;HDAC4;SRC;CREB5;H2BC4;RB1;LTBR;BAK1;STAT5A;HLA-G;HLA-C;DDX3X;GSN;JAK3;HLA-E;H2BC21;EP300;HLA-B;CREBBP;RBPJ;CDKN1A;REL;NFKBIA;GTF2B;GRB2;PMAIP1;HLA-F;HLA-A;CREB1;ATP6V0D1;NFKB2;MDM2;ACTN1;GTF2H2;RAC1;H4C5;GTF2H2C;ATF2;YWHAG;KRAS;HNRNPK;YWHAB;PIK3CA;CDC42;NFKB1;CASP8;KAT2B;NRAS;YWHAE;CASP3;GTF2A1;CREB3L2;SYK;SRF;H2BC5;H2BC12;RHOA;STAT5B;ACTN4;MAPK1;TRAF3;HDAC7;CCR3;YWHAZ;H2BC7;CDK6;H4C14;IKBKG
32,prerank,Inflammatory bowel disease,0.6247809213123224,1.878881352870244,0.0,0.0016407242013953289,0.044,18/45,10.68%,STAT1;NOD2;STAT3;IL1B;TLR2;HLA-DMB;TLR4;HLA-DRA;TNF;HLA-DMA;HLA-DQB1;IL12RB1;TLR5;HLA-DPA1;IFNGR2;HLA-DRB1;HLA-DRB5;TGFB1
33,prerank,Proteasome,0.6255600946955172,1.876871499278076,0.0,0.0016240048651039363,0.045,18/42,22.50%,PSME2;PSMB9;PSME1;PSMB8;PSMB10;PSMA4;PSMB3;PSMA3;POMP;PSMB2;PSMA5;PSMB4;PSMA2;PSMA6;PSMD3;PSMD12;PSMA1;PSMB1
34,prerank,Cytosolic DNA-sensing pathway,0.6137558053954932,1.8768172905652047,0.0,0.001574792596464423,0.045,13/44,11.82%,CXCL10;IRF7;AIM2;ZBP1;ADAR;CASP1;IL1B;TBK1;CGAS;RIPK1;NFKBIA;TREX1;CHUK
35,prerank,Cell adhesion molecules,0.5555626837609338,1.8441367874195278,0.0,0.00292686734136379,0.082,31/78,14.74%,CD274;ICAM1;PDCD1LG2;SDC3;SIGLEC1;NECTIN2;SELL;CD40;MPZL1;HLA-DMB;PTPRC;HLA-DRA;HLA-DMA;VCAN;HLA-G;HLA-C;HLA-DQB1;HLA-E;HLA-DPA1;HLA-B;NTNG2;F11R;ITGA4;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;LRRC4;SELP;CD86;SELPLG
36,prerank,Herpes simplex virus 1 infection,0.4916828188014328,1.8398237048401935,0.0,0.003095975232198142,0.09,55/330,11.27%,STAT1;OAS3;STAT2;IFIH1;OAS1;PML;TAP2;TAP1;IRF7;OAS2;FAS;JAK2;EIF2AK2;IRF9;CCL2;BST2;NECTIN2;ZNF267;ZNF200;TAPBP;SP100;IL1B;SOCS3;TLR2;SRC;TBK1;RNASEL;HLA-DMB;BAK1;B2M;HLA-DRA;TNFRSF1A;TNF;CGAS;HLA-DMA;IFNAR2;HLA-G;HLA-C;HLA-DQB1;ZNF107;IFNAR1;HLA-E;BID;CD74;HLA-DPA1;HLA-B;PILRA;MYD88;PDIA3;IFNGR2;NFKBIA;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A
37,prerank,Human papillomavirus infection,0.49866754078743414,1.8194140005323982,0.0,0.0036856848002358843,0.107,68/200,18.30%,STAT1;STAT2;ISG15;OASL;MX1;IRF1;FAS;EIF2AK2;IRF9;MX2;PTGS2;TBK1;HES4;TCF7L2;CREB5;ATP6V1B2;RB1;BAK1;TNFRSF1A;TNF;IFNAR2;NOTCH2;HLA-G;HLA-C;SOS1;IFNAR1;NOTCH1;ATP6V1G1;PPP2R2A;HLA-E;ATP6V1A;EP300;HLA-B;CREBBP;RBPJ;CDKN1A;PTGER4;MAML3;FZD2;ITGA4;PTEN;PSEN1;GSK3B;GRB2;HLA-F;CSNK1A1;APC;HLA-A;CREB1;ATP6V0D1;CHUK;MDM2;TCIRG1;KRAS;PPP2R5B;TICAM1;PIK3CA;ITGB3;CDC42;NFKB1;CASP8;PPP2CB;NRAS;PPP2CA;RAF1;SOS2;ATP6V1C1;CASP3
38,prerank,Human immunodeficiency virus 1 infection,0.5124038945067249,1.8190922280535853,0.0,0.0036159556283395294,0.108,65/168,20.22%,TAP2;TAP1;FAS;TRIM5;GNB4;LIMK2;BST2;SAMHD1;LIMK1;TAPBP;APOBEC3A;GNG10;APOBEC3B;TLR2;CUL1;TBK1;BAK1;B2M;TLR4;TNFRSF1A;PAK1;TNF;CGAS;HLA-G;APOBEC3G;HLA-C;MAPK14;PTK2B;RIPK1;HLA-E;BID;GNAQ;HLA-B;MYD88;PDIA3;PAK2;APOBEC3F;NFKBIA;AP1S2;HLA-F;HLA-A;PPP3R1;CHUK;AP1G1;RAC1;GNAI3;ITPR2;TNFRSF1B;CRK;TAB2;KRAS;PIK3CA;NFKB1;CASP8;CUL4B;GNB1;NRAS;RAF1;CASP3;APOBEC3C;GNG5;TRAF6;CALML4;PRKCB;GNB2
39,prerank,Rheumatoid arthritis,0.5658561324842479,1.816041761266292,0.001199040767386091,0.0036953839707628204,0.113,33/61,22.68%,ICAM1;TNFSF13B;CCL2;IL1B;TLR2;IL15;HLA-DMB;ATP6V1B2;CTSL;TLR4;HLA-DRA;TNF;HLA-DMA;HLA-DQB1;ATP6V1G1;HLA-DPA1;ATP6V1A;CSF1;HLA-DRB1;HLA-DRB5;TGFB1;ATP6V0D1;TCIRG1;CD86;HLA-DPB1;ATP6V1C1;ATP6V1E1;TNFSF13;HLA-DQA1;ATP6V1D;ATP6V0A1;ATP6V1C2;ITGAL
40,prerank,Viral myocarditis,0.6042036409592273,1.8139521476723186,0.0013003901170351106,0.003657333378695608,0.114,23/43,18.30%,ICAM1;EIF4G3;CD40;HLA-DMB;HLA-DRA;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;HLA-E;BID;HLA-DPA1;HLA-B;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;RAC1;CD86;HLA-DPB1;CASP8;ACTB;CASP3
41,prerank,Pathogenic Escherichia coli infection,0.510032433958463,1.8024161132372118,0.0,0.004312251216275984,0.135,63/142,22.88%,TNFSF10;FAS;CASP1;CASP7;CASP4;SEC24D;IL1B;SRC;FCGR2A;GNA13;BAK1;TLR4;TNFRSF1A;PAK1;TNF;CYTH4;MAPK14;TLR5;WIPF1;ACTR2;RIPK1;NAIP;RAB1A;MYD88;ACTR3;ARPC5;PAK2;ABI1;PTPN6;NFKBIA;WIPF2;CHUK;LPAR1;TAB3;NLRP3;ARPC3;ROCK1;CYFIP1;RAC1;TAB2;TUBA1A;TUBB1;CDC42;NFKB1;LPAR2;CASP8;ARHGEF11;MYO1F;ACTB;ROCK2;SEC24B;CASP3;ARF6;TNFRSF10B;SEC24A;TRAF6;ARHGEF2;TMBIM6;RHOA;PTPN11;ARF1;MAPK1;PYCARD
42,prerank,Intestinal immune network for IgA production,0.6323713473789352,1.799089976927794,0.0,0.00442282176028306,0.139,14/33,10.68%,TNFSF13B;IL15RA;IL15;CD40;HLA-DMB;LTBR;HLA-DRA;HLA-DMA;HLA-DQB1;HLA-DPA1;ITGA4;HLA-DRB1;HLA-DRB5;TGFB1
43,prerank,Type I diabetes mellitus,0.6507858374135591,1.7941225016282802,0.001388888888888889,0.0045281270402898,0.146,18/28,16.14%,FAS;IL1B;HLA-DMB;HLA-DRA;TNF;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;HLA-E;HLA-DPA1;HLA-B;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;CD86;HLA-DPB1
44,prerank,Allograft rejection,0.6438158948510735,1.775259330793194,0.002777777777777778,0.006042808800386741,0.196,18/27,16.14%,FAS;CD40;HLA-DMB;HLA-DRA;TNF;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;HLA-E;HLA-DPA1;HLA-B;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;CD86;HLA-DPB1
45,prerank,Transcriptional misregulation in cancer,0.5089564983661197,1.774707529730105,0.0,0.005955731574926622,0.197,40/123,17.73%,ETV7;FCGR1A;PML;AFF1;GADD45B;DUSP6;BCL6;ETV6;JMJD1C;CD40;LMO2;BAK1;H3-3A;CEBPB;SP1;NFKBIZ;CDKN1A;MAX;REL;H3C6;KDM6A;H3C4;H3-3B;HHEX;SPI1;RARA;MDM2;H3-5;BCL2A1;TFE3;BIRC2;CD86;BMP2K;CCNT2;ELK4;NFKB1;TGFBR2;POLK;MEF2C;RUNX1
46,prerank,Coronavirus disease,-0.368769359191012,-1.7695105941188414,0.0,0.02766848816029144,0.134,75/170,7.21%,RPS27;RPL13A;RPS18;RPL3;RPS5;RPL13;RPS15A;RPL36;RPL37A;RPS21;RPS19;RPSA;RPL18A;RPS3;RPLP2;RPS28;RPL10A;RPL23A;RPS6;RPL39;RPS20;RPL10;RPLP0;RPL18;RPL9;RPL32;RPS16;RPS14;RPL7A;RPS10;RPL27A;RPS25;RPL30;RPL29;RPS17;RPL35;RPS4X;RPS15;RPL12;RPL37;RPL4;RPS23;RPS29;RPS7;RPL14;RPL5;RPL27;RPL38;RPL41;RPS3A;RPS8;RPL24;RPL8;RPL19;RPS13;RPLP1;RPL35A;RPS2;RPS10-NUDT3;RPS27A;RPL11;RPL17;RPS12;RPL22;RPS26;RPL6;RPS11;RPL23;JUN;RPL26;RPL15;RPL31;RPL7;RPL21;FAU
47,prerank,Endocytosis,0.4778322685177074,1.7515199655098328,0.0,0.0080593640965158,0.246,83/205,21.44%,PML;CHMP5;IGF2R;SRC;HSPA6;RAB31;KIF5B;ACAP2;HLA-G;HLA-C;CYTH4;CAPZA2;RAB11FIP1;RAB5A;WASHC4;SMAP2;WIPF1;ACTR2;HLA-E;SNX6;CBL;FOLR2;HLA-B;STAM2;ARRB2;SH3GLB1;CAPZA1;ACTR3;ARPC5;CHMP2B;LDLR;ARF3;RAB10;IQSEC1;SPART;WASHC2C;RAB5C;ASAP1;CXCR2;WIPF2;VPS37C;HLA-F;RAB11FIP4;RAB8A;EPS15;WASHC2A;HLA-A;MDM2;PIP5K1A;ARPC3;GRK3;VPS4B;TGFBR1;ARAP2;ITCH;ZFYVE16;CLTC;GIT2;EHD1;HSPA8;CDC42;TGFBR2;USP8;CXCR1;ARAP1;RAB11A;SNX2;CHMP1B;RAB7A;MVB12A;ARF6;RAB22A;IGF1R;CHMP3;TRAF6;SPG21;RNF103-CHMP3;CHMP2A;SNX1;SNX3;CHMP4B;TSG101;RHOA
48,prerank,"Growth hormone synthesis, secretion and action",0.5205852730627449,1.7422523034930208,0.0,0.00942253331538565,0.289,33/78,22.58%,STAT1;SOCS1;JAK2;STAT3;SOCS3;CREB5;STAT5A;JUNB;MAPK14;SOS1;GNAQ;EP300;CREBBP;GSK3B;GRB2;CREB1;GNAI3;ITPR2;CRK;ATF2;KRAS;MAP2K4;PIK3CA;MAP3K1;NRAS;RAF1;SOS2;CREB3L2;PRKCB;ADCY3;STAT5B;ADCY7;MAPK1
49,prerank,Ubiquitin mediated proteolysis,0.4995415397228824,1.736468992293765,0.0,0.010351284970875247,0.313,45/124,23.53%,UBE2L6;SOCS1;PML;SOCS3;CUL1;UBE2D1;UBE2D3;XIAP;FANCL;UBE2J1;HERC3;UBE2S;CBL;PIAS1;COP1;TRIP12;UBE2W;UBR5;UBE2B;MDM2;CUL3;BIRC2;ITCH;UBA6;UBE2Z;UBE2A;UBA3;CUL4B;UBE4A;UBE2R2;MAP3K1;WWP2;CDC27;UBA7;FBXW7;UBE2E1;UBE2K;UBA1;TRAF6;CUL2;CUL5;FBXW11;UBE2F;HERC4;UBE2C
50,prerank,Chemokine signaling pathway,0.4917056074384145,1.7294859393425404,0.0,0.011195267580716498,0.337,56/131,21.93%,STAT1;CXCL10;STAT2;JAK2;GNB4;CCR1;CCL2;NCF1;CXCL16;STAT3;LYN;GNG10;CCR2;SRC;PAK1;FGR;SOS1;JAK3;PTK2B;HCK;GNAQ;ARRB2;WAS;PRKCD;GSK3B;NFKBIA;GRB2;CXCR2;PREX1;CHUK;ROCK1;RAC1;GRK3;GNAI3;CRK;KRAS;PIK3CA;CDC42;NFKB1;CXCR1;PIK3CG;ROCK2;GNB1;NRAS;PIK3R5;RAP1A;RAF1;SOS2;GNG5;PRKCB;GNB2;ADCY3;VAV1;RHOA;STAT5B;ADCY7
51,prerank,B cell receptor signaling pathway,0.5187189605165712,1.7213487015793387,0.0012106537530266344,0.011801713166469593,0.355,34/76,21.23%,PIK3AP1;DAPP1;LYN;IFITM1;LILRB1;LILRB3;LILRB4;LILRA6;FCGR2B;SOS1;NFKBIE;LILRB2;LILRA1;PTPN6;GSK3B;NFKBIA;LILRB5;GRB2;PPP3R1;CHUK;BCL10;RAC1;KRAS;PIK3CA;NFKB1;RASGRP3;NRAS;RAF1;SOS2;SYK;PRKCB;INPPL1;LILRA5;VAV1
52,prerank,Salmonella infection,0.47048446576999936,1.7135587088728674,0.0,0.012560813799203891,0.375,99/211,28.65%,TNFSF10;CASP5;CASP1;DYNLT1;RIPK2;MLKL;CASP7;CASP4;IL1B;TLR2;GSDMD;TCF7L2;KIF5B;BAK1;PTPRC;TLR4;TNFRSF1A;PAK1;TNF;CYTH4;NOD1;MAPK14;RAB5A;LY96;TLR5;ACTR2;RIPK1;TLR6;NAIP;NLRC4;MYD88;ACTR3;ARPC5;ABI1;ARL8B;NFKBIA;RAB5C;KPNA4;RHOB;CHUK;TAB3;NLRP3;ARPC3;VPS41;CYFIP1;RAC1;DYNC1LI1;BIRC2;TAB2;MAP2K4;TUBA1A;HSP90AA1;TUBB1;PIK3CA;CDC42;NFKB1;CASP8;ELMO2;PIK3CG;ACTB;ROCK2;RAB7A;RAF1;CASP3;DCTN4;ARF6;TNFRSF10B;TRAF6;PIK3C2A;RILP;ARL8A;RHOA;ARF1;PLEKHM2;MAPK1;PYCARD;ACTR10;HSP90B1;ANXA2;EXOC5;IKBKG;TUBA1B;DYNC1LI2;RHOG;CD14;TUBA1C;IRAK4;PIK3CB;DCTN6;TCF7L1;RELA;KPNA3;GCC2;MYL12A;PLEKHM1;CTNNB1;ACBD3;RAB5B;MAP3K7
53,prerank,Autoimmune thyroid disease,0.6194521074091948,1.7134565677625844,0.008438818565400843,0.012314523332552837,0.375,17/27,16.14%,FAS;CD40;HLA-DMB;HLA-DRA;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;HLA-E;HLA-DPA1;HLA-B;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A;CD86;HLA-DPB1
54,prerank,Yersinia infection,0.49466826788291235,1.700635427740185,0.0,0.014204062191678291,0.414,47/119,18.81%,FYB1;CASP1;CCL2;MEFV;LIMK1;LCP2;IL1B;SRC;FCGR2A;TBK1;TLR4;PKN2;TNF;MAPK14;SKAP2;PTK2B;WIPF1;ACTR2;GNAQ;WAS;NLRC4;MYD88;ACTR3;ARPC5;ITGA4;GSK3B;NFKBIA;WIPF2;CHUK;PIP5K1A;NLRP3;ARPC3;ROCK1;RAC1;CRK;TAB2;GIT2;MAP2K4;TICAM1;PIK3CA;CDC42;NFKB1;ELMO2;ACTB;ROCK2;ARF6;RPS6KA3
55,prerank,Asthma,0.6664734120238138,1.697854473802611,0.01046337817638266,0.014478482554888887,0.425,10/18,10.66%,CD40;HLA-DMB;HLA-DRA;TNF;HLA-DMA;HLA-DQB1;HLA-DPA1;FCER1G;HLA-DRB1;HLA-DRB5
56,prerank,Shigellosis,0.4578522410523096,1.670016796686231,0.0,0.01986174586793782,0.532,89/200,27.67%,TIFA;CASP1;RBCK1;RIPK2;CALCOCO2;CASP4;IL1B;SRC;CUL1;UBE2D1;TBK1;RNF31;TLR4;TNFRSF1A;UBE2D3;TNF;CGAS;H3-3A;CYTH4;NOD1;MAPK14;TLR5;ACTR2;RIPK1;ILK;NAIP;PRKCD;NLRC4;MYD88;ACTR3;ARPC5;TLN1;H3C6;H3C4;GSK3B;NFKBIA;H3-3B;RRAGC;CHUK;BCL10;TAB3;MDM2;H3-5;NLRP3;ARPC3;ACTN1;HK1;ROCK1;RAC1;ITPR2;CRK;TAB2;PIK3CA;CDC42;NFKB1;GABARAP;ELMO2;ACTB;RPS6KA5;ROCK2;BECN1;FNBP1;ARF6;TRAF6;HK2;ARHGEF2;RHOA;CAST;ARF1;FBXW11;ACTN4;MAPK1;SQSTM1;PYCARD;HK3;GABARAPL2;UBE2V2;IKBKG;CD14;NFKBIB;CRKL;FOXO4;PIK3CB;RELA;FOXO3;PPID;WASF2;MYL12A;PXN
57,prerank,Acute myeloid leukemia,0.5240299152966018,1.6677504742248717,0.0012437810945273632,0.019963009127095817,0.541,21/59,18.19%,FCGR1A;PML;DUSP6;STAT3;PIM2;TCF7L2;STAT5A;SOS1;PIM1;GRB2;SPI1;RARA;CHUK;BCL2A1;KRAS;PIK3CA;NFKB1;NRAS;RUNX1;RAF1;SOS2
58,prerank,Tryptophan metabolism,0.6020184576158323,1.6663667639192563,0.008571428571428572,0.01988295318127251,0.548,6/25,16.37%,IDO1;AANAT;IL4I1;DHTKD1;KMO;ALDH2
59,prerank,Pathways in cancer,0.44197893655071985,1.6609600263503785,0.0,0.020853216632913552,0.574,120/311,22.70%,STAT1;STAT2;PML;FAS;JAK2;GNB4;GADD45B;CSF2RB;RALB;IL13RA1;STAT3;IL15RA;CASP7;PIM2;GNG10;PTGS2;IL15;CUL1;EGLN1;TCF7L2;GNA13;RB1;BAK1;STAT5A;GSTO1;XIAP;IFNAR2;NOTCH2;IL12RB1;SOS1;SP1;IFNAR1;NFE2L2;JAK3;NOTCH1;NCOA1;IL6R;HIF1A;BID;CTNNA1;GNAQ;CBL;CAMK2D;EP300;CREBBP;CDKN1A;MAX;TFG;PTGER4;FZD2;PIM1;IFNGR2;PTEN;GSK3B;NFKBIA;CSF3R;GRB2;NCOA3;NCOA4;PMAIP1;TGFB1;SPI1;APC;RARA;LPAR6;NFKB2;CHUK;LPAR1;MDM2;RASSF5;ROCK1;APAF1;RAC1;TGFBR1;GNAI3;BIRC2;CRK;KRAS;HSP90AA1;PIK3CA;CDC42;NFKB1;TGFBR2;LPAR2;POLK;CASP8;RASGRP4;ARHGEF11;RPS6KA5;ROCK2;RASGRP3;GNB1;NRAS;RUNX1;RAF1;BCL2L11;SOS2;CASP3;RALBP1;GNG5;NKX3-1;IGF1R;TRAF6;CALML4;PRKCB;E2F2;GNB2;ADCY3;CUL2;TPM3;STK4;CALM2;RHOA;STAT5B;FRAT2;ADCY7;FRAT1;GLI1;MAPK1;TRAF3
60,prerank,IL-17 signaling pathway,0.5228916470355651,1.6587476595583572,0.0012285012285012285,0.021122786682731168,0.582,31/57,25.55%,CXCL10;CCL2;IL1B;PTGS2;USP25;TBK1;TNF;MAPK14;CEBPB;IL17RA;GSK3B;NFKBIA;CHUK;TAB3;TNFAIP3;IL17RC;TAB2;HSP90AA1;NFKB1;CASP8;CASP3;TRAF6;S100A8;MAPK1;TRAF3;HSP90B1;MAPK6;S100A9;IKBKG;JUND;SRSF1
61,prerank,Alcoholism,0.48308026212047944,1.6380562289191378,0.0011441647597254005,0.026518189791527674,0.66,46/103,26.51%,H2BC18;GNB4;H4C8;GNG10;HDAC4;CREB5;H2BC4;H3-3A;H2AC19;H2AC18;SOS1;H2BC21;H2AC7;H3C6;H3C4;GRB2;H3-3B;H2AC20;CREB1;H3-5;H4C5;GNAI3;ATF2;KRAS;GNB1;NRAS;RAF1;SOS2;GNG5;PPP1CB;CREB3L2;CALML4;GNB2;H2BC5;H2BC12;CALM2;MAPK1;HDAC7;H2BC7;H4C14;CAMKK2;H4C15;H2AC6;BRAF;SHC1;PPP1CC
62,prerank,Cholesterol metabolism,0.5836682653700813,1.6235583163802132,0.007183908045977011,0.030259472209936605,0.704,10/26,15.61%,SORT1;CETP;NPC2;CD36;PLTP;ABCA1;LDLR;LIPA;MYLIP;NCEH1
63,prerank,AGE-RAGE signaling pathway in diabetic complications,0.5075764472039407,1.6231056591454216,0.007585335018963337,0.02989029951929003,0.707,22/63,18.30%,STAT1;ICAM1;JAK2;CYBB;CCL2;STAT3;IL1B;STAT5A;TNF;MAPK14;PRKCD;PIM1;TGFB1;RAC1;TGFBR1;KRAS;PIK3CA;CDC42;NFKB1;TGFBR2;NRAS;CASP3
64,prerank,Legionellosis,0.5266505583121575,1.6153974799171646,0.003778337531486146,0.03224379734916038,0.732,32/49,31.00%,CASP1;CASP7;IL1B;TLR2;HSPA6;TLR4;TNF;TLR5;NAIP;RAB1A;NLRC4;MYD88;NFKBIA;NFKB2;APAF1;HSPA8;NFKB1;CASP8;CASP3;SEC22B;ARF1;PYCARD;SAR1A;CD14;RAB1B;RELA;SAR1B;HSPA1B;ITGB2;HSPD1;HSPA1A;CR1L
65,prerank,Chronic myeloid leukemia,0.4884070200933938,1.6103711771849114,0.007425742574257425,0.033434426402139804,0.746,36/67,27.09%,GADD45B;RB1;BAK1;STAT5A;SOS1;CBL;CDKN1A;GAB2;NFKBIA;GRB2;TGFB1;CHUK;MDM2;TGFBR1;CRK;KRAS;PIK3CA;NFKB1;TGFBR2;POLK;NRAS;RUNX1;RAF1;SOS2;E2F2;PTPN11;STAT5B;MAPK1;CDK6;IKBKG;CRKL;BRAF;SHC1;PIK3CB;CTBP2;RELA
66,prerank,Graft-versus-host disease,0.5657905104206173,1.600845982384778,0.01652892561983471,0.03638461963732862,0.773,16/31,11.27%,FAS;IL1B;HLA-DMB;HLA-DRA;TNF;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;HLA-E;HLA-DPA1;HLA-B;HLA-DRB1;HLA-DRB5;HLA-F;HLA-A
67,prerank,NF-kappa B signaling pathway,0.48094261367336194,1.5992877673126338,0.007100591715976331,0.03647126866941108,0.78,31/86,16.45%,ICAM1;TNFSF13B;GADD45B;TRIM25;LYN;IL1B;PTGS2;CD40;TICAM2;LTBR;TLR4;TNFRSF1A;TNF;CFLAR;XIAP;RELB;CYLD;LY96;RIPK1;MYD88;NFKBIA;NFKB2;CHUK;BCL10;TAB3;TNFAIP3;BCL2A1;BIRC2;TAB2;TICAM1;NFKB1
68,prerank,Epithelial cell signaling in Helicobacter pylori infection,0.5084863191515001,1.5992152995200222,0.004895960832313341,0.035952179915028214,0.78,29/54,21.89%,LYN;SRC;ATP6V1B2;PAK1;NOD1;MAPK14;ATP6V1G1;ATP6V1A;F11R;NFKBIA;CXCR2;ATP6V0D1;CHUK;TCIRG1;RAC1;ADAM10;MAP2K4;ADAM17;CDC42;NFKB1;CXCR1;ATP6V1C1;CASP3;ATP6V1E1;ATP6V1D;CSK;ATP6V0A1;PTPN11;ATP6V1C2
69,prerank,Chagas disease,0.4840559845003989,1.5848411276640286,0.009535160905840286,0.04074607061992118,0.813,30/75,17.99%,FAS;C1QB;CCL2;IL1B;TLR2;C1QC;TLR4;TNFRSF1A;TNF;CFLAR;MAPK14;PPP2R2A;TLR6;GNAQ;MYD88;C1QA;IFNGR2;NFKBIA;TGFB1;CHUK;TGFBR1;GNAI3;MAP2K4;TICAM1;PIK3CA;NFKB1;TGFBR2;CASP8;PPP2CB;PPP2CA
70,prerank,Lysosome,0.457780850779849,1.5692436027668955,0.0033519553072625698,0.04689491895829539,0.858,41/115,21.56%,LAMP3;SORT1;NPC2;GNS;SCARB2;IGF2R;CTSA;GM2A;CTSS;CTSL;GALC;LAMP2;CTSZ;ARSB;LITAF;AP1S2;CD164;CTSB;CTSO;ATP6V0D1;LIPA;AP1G1;TCIRG1;TPP1;GLA;CLTC;AP3B1;CD68;ACP2;PSAP;NAGA;ASAH1;ENTPD4;LAPTM4A;GLB1;LAMP1;FUCA2;GALNS;CD63;ATP6V0A1;PPT1
71,prerank,GABAergic synapse,0.5417236272452199,1.5655543445738487,0.025,0.04810619900133966,0.869,16/35,21.93%,SLC6A12;GNB4;GNG10;SRC;GLS;GLUL;SLC38A2;GNAI3;GABARAP;GNB1;GNG5;PRKCB;NSF;GNB2;ADCY3;ADCY7
72,prerank,Arachidonic acid metabolism,-0.4393997627039882,-1.5639356210612652,0.02214022140221402,0.1185792349726776,0.53,13/30,12.33%,PTGDS;GPX3;EPHX2;PLA2G4B;PLB1;JMJD7-PLA2G4B;GGT1;PLA2G6;AKR1C3;LTC4S;GPX7;ALOX15;PRXL2B
73,prerank,Cholinergic synapse,0.487254957632012,1.55409631729942,0.020151133501259445,0.05315284008340178,0.901,24/61,22.58%,KCNJ2;JAK2;GNB4;CHRNB2;GNG10;CREB5;GNAQ;CAMK2D;CREB1;GNAI3;ITPR2;KRAS;PIK3CA;PIK3CG;GNB1;NRAS;PIK3R5;GNG5;CREB3L2;PRKCB;GNB2;ADCY3;ADCY7;MAPK1
74,prerank,Human T-cell leukemia virus 1 infection,0.42888947106629305,1.5488219328483868,0.0010683760683760685,0.05488036578604756,0.909,55/174,17.68%,ICAM1;POLB;IL15RA;IL15;CD40;CREB5;HLA-DMB;RB1;LTBR;B2M;STAT5A;HLA-DRA;TNFRSF1A;TNF;XIAP;ZFP36;HLA-DMA;HLA-G;HLA-C;HLA-DQB1;RELB;JAK3;HLA-E;HLA-DPA1;EP300;HLA-B;CREBBP;CDKN1A;TLN1;PTEN;NFKBIA;HLA-DRB1;HLA-DRB5;TGFB1;SPI1;HLA-F;HLA-A;PPP3R1;CREB1;NFKB2;CHUK;TGFBR1;ATF2;KRAS;MAP2K4;ELK4;PIK3CA;HLA-DPB1;NFKB1;TGFBR2;KAT2B;MAP3K1;NRAS;CDC27;ETS2
75,prerank,Regulation of actin cytoskeleton,0.4380379183097239,1.5388159619725783,0.005549389567147614,0.05980023588382721,0.928,54/128,27.67%,LIMK2;LIMK1;SRC;GNA13;PAK1;SOS1;GSN;IQGAP1;ACTR2;ACTR3;ARPC5;PAK2;ITGA4;SPATA13;PPP1R12A;APC;PIKFYVE;LPAR1;PIP5K1A;ARPC3;ACTN1;ROCK1;CYFIP1;RAC1;SSH2;CRK;IQGAP2;KRAS;PIK3CA;ITGB3;CDC42;LPAR2;ACTB;DIAPH2;ROCK2;NRAS;RAF1;SOS2;PPP1CB;VAV1;RHOA;ACTN4;MAPK1;ITGAL;ITGAX;MSN;RDX;CRKL;BRAF;PIK3CB;PPP1CC;WASF2;MYL12A;PXN
76,prerank,Collecting duct acid secretion,0.5974872597632048,1.5383829893652952,0.050221565731166914,0.05919310766844589,0.928,12/19,21.89%,ATP6V1B2;CA2;ATP6V1G1;ATP6V1A;ATP6V0D1;TCIRG1;ATP6V1C1;ATP6V1E1;SLC12A7;ATP6V1D;ATP6V0A1;ATP6V1C2
77,prerank,Protein processing in endoplasmic reticulum,0.43235387435640227,1.5345298421276865,0.004343105320304018,0.06058966972279667,0.93,48/151,24.05%,FBXO6;EIF2AK2;DNAJA1;MAN1A1;SEC24D;CUL1;UBE2D1;HSPA6;BAK1;DNAJC1;UBE2D3;ATF6;UBE2J1;UBQLN2;SEL1L;NFE2L2;PPP1R15A;PDIA3;RNF185;MAP3K5;EDEM2;UBXN4;HSPA5;DERL1;MMP24-AS1-EDEM2;EDEM1;SSR1;DNAJB11;OS9;HSP90AA1;HSPA8;DNAJC3;PDIA6;EDEM3;SEC24B;SEC24A;DNAJB12;TRAM1;HSPH1;YOD1;DNAJC5;HERPUD1;SAR1A;RAD23B;HSP90B1;EIF2S1;SEC23B;MARCHF6
78,prerank,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.46087714513361794,1.53232057824872,0.016355140186915886,0.06082854194309303,0.934,25/82,18.11%,BATF2;CD274;STAT1;JAK2;STAT3;TLR2;TICAM2;TLR4;MAPK14;NFKBIE;HIF1A;MYD88;IFNGR2;PTEN;PTPN6;NFKBIA;PPP3R1;CHUK;KRAS;TICAM1;PIK3CA;NFKB1;NRAS;BATF3;RAF1
79,prerank,Apoptosis,0.4355745312171358,1.5286336883306373,0.0056947608200455585,0.062137735980818926,0.94,42/122,18.30%,TNFSF10;FAS;SEPTIN4;GADD45B;LMNB1;CSF2RB;CASP7;CTSS;BAK1;CTSL;TNFRSF1A;TNF;CFLAR;XIAP;MCL1;RIPK1;BID;CTSZ;CASP10;NFKBIA;PMAIP1;MAP3K5;CTSB;CTSO;CHUK;PARP3;BCL2A1;APAF1;BIRC2;ITPR2;KRAS;TUBA1A;PIK3CA;NFKB1;CASP8;PARP4;ACTB;NRAS;BECN1;RAF1;BCL2L11;CASP3
80,prerank,"Parathyroid hormone synthesis, secretion and action",0.46664101435641997,1.5241686371779413,0.02625,0.0640160370368243,0.945,25/65,23.35%,PDE4B;MAFB;CREB5;GNA13;AKAP13;SP1;VDR;GNAQ;ARRB2;CDKN1A;MEF2A;CREB1;GNAI3;ITPR2;ATF2;ARHGEF11;MEF2C;RAF1;CREB3L2;PRKCB;ADCY3;RHOA;ADCY7;MAPK1;MMP14
81,prerank,Cytokine-cytokine receptor interaction,0.4419654734279129,1.5216838311066643,0.006711409395973154,0.06489640390569183,0.953,38/122,14.27%,CXCL10;TNFSF10;FAS;TNFSF13B;CCR1;CCL2;CSF2RB;IL27;CXCL16;IL13RA1;IL15RA;CCR2;IL1B;IL15;CD40;IL1RAP;IL1RN;LTBR;TNFRSF1A;TNF;IFNAR2;IL12RB1;IFNAR1;IL6R;IL17RA;IL10RB;CSF1;IFNGR2;CSF3R;TGFB1;CXCR2;TNFRSF10C;BMPR2;OSM;TGFBR1;IL17RC;TNFRSF1B;RELT
82,prerank,Pancreatic cancer,0.46588489555324836,1.5145167009860092,0.0171990171990172,0.06851174847020754,0.96,31/65,30.51%,STAT1;GADD45B;RALB;STAT3;RB1;BAK1;CDKN1A;TGFB1;CHUK;RAC1;TGFBR1;KRAS;PIK3CA;CDC42;NFKB1;TGFBR2;POLK;RAF1;RALBP1;E2F2;MAPK1;CDK6;IKBKG;BRAF;PIK3CB;RELA;RPS6KB1;SMAD4;E2F3;JAK1;GADD45G
83,prerank,Chemical carcinogenesis,0.4352671559488934,1.5082162314600902,0.01020408163265306,0.07173264042459089,0.966,46/118,22.58%,JAK2;CHRNB2;BCL6;KLF5;STAT3;PTGS2;SRC;KPNB1;CREB5;RB1;STAT5A;GSTO1;XIAP;NOTCH2;MIR29B2;SOS1;VDR;KLF4;ARRB2;GSTK1;GRB2;CBR1;KPNA4;CREB1;MIR29C;GNAI3;ATF2;KRAS;MIRLET7I;HSP90AA1;PIK3CA;NFKB1;NRAS;RAF1;SOS2;MIRLET7F1;RPS6KA3;CREB3L2;PRKCB;PTGES3;ADCY3;CYP1B1;STAT5B;ADCY7;AHR;MAPK1
84,prerank,Gastric acid secretion,0.5059793589836118,1.504925291354028,0.04521276595744681,0.07264894261798287,0.967,14/37,21.93%,KCNJ2;KCNJ15;ATP1B3;CA2;GNAQ;CAMK2D;GNAI3;ITPR2;ACTB;CALML4;PRKCB;ADCY3;CALM2;ADCY7
85,prerank,Adipocytokine signaling pathway,0.48431814995220895,1.5007703064735034,0.02756892230576441,0.07454072771599012,0.971,27/50,29.14%,JAK2;ACSL4;STAT3;SOCS3;CD36;TNFRSF1A;TNF;NFKBIE;ACSL1;ACSL5;NFKBIA;CHUK;TNFRSF1B;PRKAG2;CPT1B;NFKB1;ACSL3;PTPN11;IKBKG;CAMKK2;NFKBIB;PRKAA1;PRKAG1;RELA;ADIPOR2;RXRA;PCK2
86,prerank,Neurotrophin signaling pathway,0.44264034305038225,1.493242215254629,0.013048635824436536,0.07813207718090406,0.974,48/95,27.09%,SORT1;RIPK2;SH2B3;MAPK14;SOS1;NFKBIE;CAMK2D;PRKCD;SH2B2;IRAK2;PSEN1;GSK3B;NFKBIA;GRB2;PSEN2;KIDINS220;MAP3K5;IRAK3;RAC1;CRK;KRAS;PIK3CA;CDC42;NFKB1;RPS6KA5;MAP3K1;NRAS;RAP1A;YWHAE;RAF1;SOS2;RPS6KA3;PDPK1;TRAF6;CALML4;CALM2;RHOA;PTPN11;MAPK1;FRS2;NFKBIB;CRKL;IRAK4;BRAF;SHC1;PIK3CB;RELA;FOXO3
87,prerank,Proteoglycans in cancer,0.42468230486131286,1.4799403556147386,0.007865168539325843,0.08698216128556685,0.984,46/122,21.50%,FAS;MIR21;STAT3;PLAUR;HPSE;TLR2;SRC;CTSL;TLR4;PAK1;TNF;MAPK14;SOS1;IQGAP1;HIF1A;CBL;CAMK2D;CDKN1A;FZD2;PTPN6;GRB2;TGFB1;PPP1R12A;MDM2;ROCK1;RAC1;ITPR2;KRAS;PDCD4;PIK3CA;ITGB3;CDC42;ACTB;ROCK2;NRAS;RAF1;SOS2;CASP3;IGF1R;PPP1CB;PDPK1;PRKCB;CD63;VAV1;RHOA;PTPN11
88,prerank,SNARE interactions in vesicular transport,0.5181613995194948,1.4723292114900874,0.05234159779614325,0.09137029424773005,0.988,5/31,6.89%,VAMP5;STX11;VAMP3;STX3;STX17
89,prerank,Adherens junction,0.473643915739908,1.4499298033663486,0.03780964797913951,0.10803770712691443,0.995,30/48,28.65%,NECTIN2;SRC;TCF7L2;PTPRJ;IQGAP1;CTNNA1;EP300;CREBBP;WAS;PTPN1;PTPN6;NLK;ACTN1;RAC1;TGFBR1;CDC42;TGFBR2;ACTB;IGF1R;FARP2;CTNND1;RHOA;ACTN4;MAPK1;INSR;TCF7L1;WASF2;CTNNB1;SMAD4;MAP3K7
90,prerank,Synaptic vesicle cycle,0.5007281316008196,1.4494212817546959,0.06578947368421052,0.10725342768686422,0.995,15/36,21.89%,SLC6A12;NAPA;STX3;ATP6V1B2;ATP6V1G1;ATP6V1A;ATP6V0D1;TCIRG1;CLTC;ATP6V1C1;ATP6V1E1;NSF;ATP6V1D;ATP6V0A1;ATP6V1C2
91,prerank,Glioma,0.4519137508017145,1.4479105940714412,0.04878048780487805,0.10706495516867034,0.995,26/56,26.14%,GADD45B;RB1;BAK1;SOS1;CAMK2D;CDKN1A;PTEN;GRB2;MDM2;CAMK1D;KRAS;PIK3CA;POLK;NRAS;RAF1;SOS2;IGF1R;CALML4;PRKCB;E2F2;CALM2;MAPK1;CDK6;BRAF;SHC1;PIK3CB
92,prerank,Ferroptosis,0.5023054772345551,1.4327078824305843,0.06141522029372497,0.11915529073841247,0.996,10/34,19.90%,CYBB;SAT1;ACSL4;ACSL1;ACSL5;NCOA4;SLC40A1;ACSL3;MAP1LC3B2;MAP1LC3B
93,prerank,Pyrimidine metabolism,0.47639241950419947,1.4312526013455462,0.05310880829015544,0.11917047520762691,0.996,7/43,7.78%,CMPK2;TYMP;NT5C3A;DPYD;NT5C2;RRM2B;ENTPD1
94,prerank,Th17 cell differentiation,0.424781088690141,1.4311263503484344,0.03909952606635071,0.11797026502908856,0.996,30/91,16.51%,STAT1;JAK2;STAT3;IL1B;HLA-DMB;IL1RAP;STAT5A;HLA-DRA;HLA-DMA;HLA-DQB1;IL12RB1;MAPK14;NFKBIE;JAK3;IL6R;HIF1A;HLA-DPA1;IFNGR2;NFKBIA;HLA-DRB1;HLA-DRB5;TGFB1;PPP3R1;RARA;CHUK;TGFBR1;HSP90AA1;HLA-DPB1;NFKB1;TGFBR2
95,prerank,Relaxin signaling pathway,0.43553576870620886,1.4284829908441892,0.02804878048780488,0.11941618752764264,0.996,32/78,22.58%,GNB4;ACTA2;GNG10;SRC;CREB5;MAPK14;SOS1;ARRB2;NFKBIA;GRB2;TGFB1;CREB1;TGFBR1;GNAI3;ATF2;KRAS;MAP2K4;PIK3CA;NFKB1;TGFBR2;GNB1;NRAS;RAF1;SOS2;GNG5;INSL3;CREB3L2;GNB2;ADCY3;GNA15;ADCY7;MAPK1
96,prerank,Non-small cell lung cancer,0.4465913220024917,1.4284275682336252,0.044929396662387676,0.11817969972369254,0.996,28/58,27.09%,GADD45B;STAT3;RB1;KIF5B;BAK1;STAT5A;SOS1;JAK3;CDKN1A;GRB2;RASSF5;KRAS;PIK3CA;POLK;NRAS;RAF1;SOS2;PDPK1;PRKCB;E2F2;STK4;STAT5B;MAPK1;EML4;CDK6;BRAF;PIK3CB;FOXO3
97,prerank,Dopaminergic synapse,0.43805939046935977,1.426973891866213,0.03645200486026731,0.11829871926374132,0.996,27/74,22.15%,GNB4;GNG10;CREB5;KIF5B;MAPK14;PPP2R2A;GNAQ;CAMK2D;ARRB2;GSK3B;CREB1;GNAI3;ITPR2;ATF2;PPP2R5B;GNB1;PPP2CB;PPP2CA;GNG5;PPP1CB;CREB3L2;CALML4;PRKCB;GNB2;PPP2R3C;CALM2;PPP2R5C
98,prerank,Axon guidance,0.4189501766518652,1.4173233416030737,0.02662037037037037,0.1262832002607137,0.997,35/92,21.50%,LIMK2;LIMK1;SRC;SRGAP2;PAK1;SEMA4B;ILK;CAMK2D;PLXNC1;DPYSL2;EPHB1;NTNG2;PLXNB2;PAK2;GSK3B;PPP3R1;SEMA4A;BMPR2;LRRC4;ROCK1;RAC1;SEMA4D;SSH2;GNAI3;KRAS;RGS3;PIK3CA;CDC42;ROCK2;NRAS;RAF1;PDPK1;FES;RHOA;PTPN11
99,prerank,Th1 and Th2 cell differentiation,0.434775280722711,1.4135243538664668,0.05080545229244114,0.1292638766032729,0.998,22/72,11.82%,STAT1;JAK2;HLA-DMB;STAT5A;HLA-DRA;HLA-DMA;NOTCH2;HLA-DQB1;IL12RB1;MAPK14;NFKBIE;JAK3;NOTCH1;HLA-DPA1;RBPJ;MAML3;IFNGR2;NFKBIA;HLA-DRB1;HLA-DRB5;PPP3R1;CHUK
100,prerank,Mucin type O-glycan biosynthesis,0.5598320680014163,1.4069922977095177,0.09351432880844646,0.13446290073272935,0.998,6/18,12.54%,B4GALT5;GALNT3;C1GALT1;C1GALT1C1;ST6GALNAC2;GCNT1
101,prerank,Notch signaling pathway,0.4622032789747233,1.3999602255054677,0.06824146981627296,0.14035689463755427,0.999,18/44,19.26%,DTX3L;CIR1;PSENEN;NOTCH2;NOTCH1;EP300;CREBBP;RBPJ;MAML3;PSEN1;PSEN2;NCSTN;NUMB;ADAM17;KAT2B;DTX2;TLE4;TLE3
102,prerank,Autophagy,0.3927146020264147,1.3931245079974364,0.031180400890868598,0.14584143067115202,0.999,50/123,26.37%,ATG3;TANK;TBK1;RAB33B;RUBCN;CTSL;CFLAR;VMP1;ATG2A;LAMP2;STX17;HIF1A;NRBF2;RAB1A;PRKCD;SH3GLB1;RB1CC1;PTEN;RRAGC;RAB8A;CTSB;MTMR4;UVRAG;KRAS;MTMR3;PIK3CA;ATG16L2;GABARAP;PPP2CB;NRAS;BECN1;RAB7A;WDR41;PPP2CA;RAF1;LAMP1;IGF1R;PDPK1;TRAF6;MAPK1;SQSTM1;SMCR8;EIF2S1;GABARAPL2;CAMKK2;MTMR14;ZFYVE1;PRKAA1;PIK3CB;AMBRA1
103,prerank,Renal cell carcinoma,0.433108978983688,1.3862362255772651,0.07161125319693094,0.1521892967713401,0.999,26/57,26.14%,EGLN1;PAK1;SOS1;HIF1A;EP300;CREBBP;CDKN1A;PAK2;GRB2;TGFB1;TFE3;RAC1;CRK;KRAS;PIK3CA;CDC42;NRAS;RAP1A;RAF1;SOS2;CUL2;PTPN11;MAPK1;CRKL;BRAF;PIK3CB
104,prerank,Morphine addiction,0.47921304223258754,1.377058916975116,0.09078590785907859,0.16199132075967435,0.999,12/35,21.93%,GNB4;PDE4B;GNG10;ARRB2;GRK3;GNAI3;GNB1;GNG5;PRKCB;GNB2;ADCY3;ADCY7
105,prerank,Type II diabetes mellitus,0.49418508193243527,1.3679860605717296,0.10128388017118402,0.17176375194040466,0.999,12/25,26.14%,SOCS1;SOCS3;TNF;PRKCD;HK1;PIK3CA;SOCS4;HK2;MAPK1;HK3;INSR;PIK3CB
106,prerank,Hematopoietic cell lineage,0.417410768636018,1.367669905312548,0.07464454976303317,0.1704074578221682,0.999,17/74,10.66%,FCGR1A;CD59;IL1B;CD36;CD38;HLA-DMB;HLA-DRA;TNF;HLA-DMA;HLA-DQB1;IL6R;HLA-DPA1;CSF1;ITGA4;CSF3R;HLA-DRB1;HLA-DRB5
107,prerank,cAMP signaling pathway,0.3990050662849724,1.3667520701975775,0.04245283018867924,0.16966199435239684,0.999,33/100,22.58%,HCAR3;FFAR2;HCAR2;PDE4B;CREB5;ATP1B3;PAK1;CAMK2D;EP300;CREBBP;NFKBIA;PPP1R12A;CREB1;ROCK1;RAC1;GNAI3;ACOX1;PIK3CA;ATP2A2;NFKB1;ROCK2;RAP1A;RAF1;PPP1CB;CREB3L2;CALML4;ADCY3;VAV1;CALM2;RHOA;ADCY7;GLI1;MAPK1
108,prerank,MAPK signaling pathway,0.37929174979478336,1.361955833032489,0.024494142705005325,0.17370105937111688,0.999,64/185,19.99%,FAS;GADD45B;DUSP6;DUSP3;DUSP5;IL1B;HSPA6;STK3;IL1RAP;TNFRSF1A;PAK1;TNF;PLA2G4A;RELB;MAPK14;SOS1;ARRB2;CSF1;MYD88;MAX;PAK2;MAP3K8;GRB2;TGFB1;MAP3K5;PPP3R1;NFKB2;CHUK;MAP3K11;TAOK1;NLK;RAC1;TGFBR1;NF1;CRK;TAB2;PPM1B;ATF2;KRAS;MAP2K4;ELK4;HSPA8;RAPGEF2;CDC42;NFKB1;TGFBR2;RASGRP4;RPS6KA5;RASGRP3;MAP3K1;NRAS;RAP1A;MEF2C;TAOK3;RAF1;SOS2;LAMTOR3;CASP3;RPS6KA3;IGF1R;MAP3K2;TRAF6;PRKCB;SRF
109,prerank,Thyroid hormone signaling pathway,0.4050914104490893,1.361096507562112,0.061004784688995214,0.17302203900428095,0.999,27/86,19.91%,STAT1;SRC;MED13L;ATP1B3;MED13;NOTCH2;NOTCH1;NCOA1;HIF1A;EP300;CREBBP;NCOA2;GSK3B;NCOA3;MDM2;MED12;KRAS;PFKFB2;PIK3CA;ITGB3;ATP2A2;ACTB;KAT2B;NRAS;RAF1;PDPK1;PRKCB
110,prerank,Spinocerebellar ataxia,0.39191498291774024,1.3589819164316623,0.052749719416386086,0.1741951084418027,0.999,37/106,26.65%,PSMA4;PSMB3;PSMA3;ATG2A;SP1;NRBF2;GNAQ;RBPJ;RB1CC1;GTF2B;PPIF;MAP3K5;PSMB2;PSMA5;PUM2;ITPR2;PSMB4;NFYA;PIK3CA;ATP2A2;PSMA2;MCU;BECN1;PUM1;PSMA6;OMA1;PRKCB;PSMD3;ATXN1;PSMD12;PSMA1;PSMB1;PSMD4;PIK3CB;AMBRA1;PSMD6;ATXN1L
111,prerank,Leukocyte transendothelial migration,0.411888796553495,1.3512146784245533,0.07023809523809524,0.18266663390502402,0.999,28/72,22.68%,ICAM1;CYBB;NCF1;MAPK14;PTK2B;NCF2;CTNNA1;VASP;F11R;ITGA4;RASSF5;ACTN1;ROCK1;RAC1;GNAI3;NCF4;PIK3CA;CDC42;ACTB;ROCK2;RAP1A;PRKCB;CTNND1;VAV1;RHOA;PTPN11;ACTN4;ITGAL
112,prerank,Viral protein interaction with cytokine and cytokine receptor,0.43371049816997825,1.3451979152842648,0.08030112923462986,0.18871044313427932,0.999,13/53,11.42%,CXCL10;TNFSF10;CCR1;CCL2;CCR2;LTBR;TNFRSF1A;TNF;IL6R;IL10RB;CSF1;CXCR2;TNFRSF10C
113,prerank,Fluid shear stress and atherosclerosis,0.39493020118294736,1.3414690777716352,0.05815279361459521,0.19193036066101082,0.999,28/90,21.44%,ICAM1;CCL2;NCF1;IL1B;SRC;CTSL;GSTO1;TNFRSF1A;TNF;MAPK14;NFE2L2;NCF2;MEF2A;MAP3K5;BMPR2;CHUK;RAC1;MAP2K4;HSP90AA1;PIK3CA;ITGB3;NFKB1;ACTB;MEF2C;CALML4;ARHGEF2;CALM2;RHOA
114,prerank,FoxO signaling pathway,0.38586365367787073,1.3382316648468695,0.05820721769499418,0.19433520207514016,0.999,43/96,27.09%,TNFSF10;SOD2;GADD45B;BCL6;STAT3;MAPK14;SOS1;EP300;CREBBP;CDKN1A;PTEN;GRB2;TGFB1;CHUK;MDM2;SETD7;NLK;TGFBR1;PRKAG2;KRAS;PIK3CA;TGFBR2;GABARAP;NRAS;RAF1;BCL2L11;SOS2;IGF1R;PDPK1;SGK3;STK4;SIRT1;MAPK1;GABARAPL2;CDKN2D;FOXO4;INSR;PRKAA1;BRAF;PIK3CB;PRKAG1;CCNG2;FOXO3
115,prerank,Mannose type O-glycan biosynthesis,-0.443898974660873,-1.336901920347776,0.1308139534883721,0.454327868852459,0.951,6/16,19.09%,POMT1;POMGNT1;B4GAT1;LARGE2;POMGNT2;B4GALT3
116,prerank,Cellular senescence,0.38206040019983845,1.3315488007931722,0.06201550387596899,0.20159379541290198,0.999,46/124,27.37%,GADD45B;NBN;HIPK3;RB1;HLA-G;HLA-C;MAPK14;HLA-E;HLA-B;CDKN1A;PTEN;RAD9B;TGFB1;HLA-F;HLA-A;PPP3R1;ZFP36L1;MDM2;RASSF5;TGFBR1;ITPR2;HIPK1;KRAS;PIK3CA;NFKB1;TGFBR2;MCU;NRAS;RAF1;ZFP36L2;PPP1CB;CALML4;E2F2;CALM2;SIRT1;FBXW11;MAPK1;SQSTM1;CDK6;LIN54;ATR;PIK3CB;PPP1CC;RELA;FOXO3;PPID
117,prerank,Bacterial invasion of epithelial cells,0.42086813642674137,1.3283490485973446,0.08944099378881988,0.20409561123005326,0.999,26/54,30.28%,SRC;CD2AP;ACTR2;ILK;CTNNA1;CBL;ACTR3;ARPC5;ARPC3;RAC1;CRK;CLTC;PIK3CA;CDC42;ELMO2;ACTB;RHOA;RHOG;CRKL;SHC1;PIK3CB;WASF2;PXN;CTNNB1;ARPC2;HCLS1
118,prerank,Rap1 signaling pathway,0.38290114506109074,1.3269552447189303,0.07150964812712826,0.2041481412509602,0.999,43/113,22.68%,DOCK4;SIPA1L1;FYB1;RALB;LCP2;SRC;PRKD2;SIPA1L2;MAPK14;GNAQ;CSF1;VASP;TLN1;APBB1IP;LPAR1;RASSF5;RAC1;FPR1;GNAI3;CRK;KRAS;PIK3CA;ITGB3;RAPGEF2;CDC42;LPAR2;ACTB;RASGRP3;NRAS;RAP1A;RAF1;IGF1R;CALML4;PRKCB;ADCY3;FARP2;CTNND1;VAV1;CALM2;RHOA;ADCY7;MAPK1;ITGAL
119,prerank,Cardiac muscle contraction,-0.33948015440140705,-1.3267825401244593,0.09595959595959595,0.3997814207650273,0.959,24/46,32.53%,TPM2;COX3;CYTB;CACNA2D2;COX2;ATP2A3;CACNB1;COX1;COX4I1;ATP1A3;UQCRH;FXYD2;CACNG6;CACNA2D3;CACNA2D4;COX7A2L;UQCR11;COX7C;MYL4;UQCR10;UQCRHL;ATP1A1;COX6C;COX6B1
120,prerank,Estrogen signaling pathway,0.40335389381842,1.3265799874313506,0.08068459657701711,0.20284406668846028,0.999,31/77,23.33%,SRC;CREB5;HSPA6;SOS1;SP1;NCOA1;GNAQ;NCOA2;PRKCD;GRB2;NCOA3;RARA;CREB1;KRT23;GNAI3;ITPR2;ATF2;KRAS;HSP90AA1;HSPA8;PIK3CA;NRAS;RAF1;SOS2;CREB3L2;CALML4;ADCY3;CALM2;ADCY7;MAPK1;HSP90B1
121,prerank,Platelet activation,0.4000434965262876,1.3249626401779955,0.07168037602820211,0.20355465235095851,0.999,31/87,22.58%,LYN;LCP2;SRC;FCGR2A;GNA13;PLA2G4A;MAPK14;GNAQ;VASP;TLN1;FCER1G;APBB1IP;PPP1R12A;ROCK1;GNAI3;ITPR2;SNAP23;PIK3CA;ITGB3;PIK3CG;ACTB;ROCK2;PIK3R5;RAP1A;TBXAS1;PPP1CB;SYK;ADCY3;RHOA;ADCY7;MAPK1
122,prerank,MicroRNAs in cancer,0.3732029930404688,1.3240244103881877,0.06586169045005488,0.20307178201915044,0.999,44/143,18.42%,SOCS1;MIR103A2;MIR21;MIR103B2;STAT3;HDAC4;PTGS2;MARCKS;GLS;BAK1;MCL1;NOTCH2;ZEB2;MIR29B2;SOS1;NOTCH1;EP300;CREBBP;CDKN1A;DICER1;PIM1;PTEN;GRB2;APC;BMPR2;MIR29C;MDM2;ROCK1;CRK;KRAS;MIRLET7I;PDCD4;HNRNPK;PIK3CA;ITGB3;NFKB1;RPS6KA5;MIR23A;NRAS;RAF1;BCL2L11;SOS2;CASP3;MIRLET7F1
123,prerank,ABC transporters,0.5065834564738592,1.3227112917296846,0.13924050632911392,0.20282198517230265,0.999,4/21,11.81%,TAP2;TAP1;ABCA1;ABCD1
124,prerank,PPAR signaling pathway,0.4499421560910673,1.322302316102647,0.12483574244415244,0.20160076414466715,0.999,7/37,8.34%,GK;ACSL4;CD36;ACSL1;PLTP;ILK;ACSL5
125,prerank,Amoebiasis,0.42661546076719387,1.3153887929911625,0.12247474747474747,0.20940218192540175,1.0,24/48,28.94%,SERPINB9;IL1B;TLR2;TLR4;TNF;RAB5A;GNAQ;RAB5C;TGFB1;ACTN1;PIK3CA;NFKB1;CD1D;RAB7A;CASP3;PRKCB;GNA15;ACTN4;CD14;PIK3CB;GNA11;RELA;RAB5B;ITGB2
126,prerank,DNA replication,-0.38243076996381076,-1.3147679924879523,0.12790697674418605,0.3683216237314598,0.968,18/30,34.44%,POLD2;MCM7;LIG1;MCM6;MCM5;RNASEH2A;MCM3;PRIM1;RPA1;RFC4;POLD1;PCNA;POLE;POLE3;RNASEH2C;RPA2;MCM2;RFC2
127,prerank,GnRH signaling pathway,0.41179733027671533,1.312968328345469,0.11866501854140915,0.21105266813119333,1.0,25/61,23.35%,SRC;PLA2G4A;MAPK14;SOS1;PTK2B;GNAQ;CAMK2D;PRKCD;GRB2;ITPR2;KRAS;MAP2K4;CDC42;MAP3K1;NRAS;RAF1;SOS2;MAP3K2;CALML4;PRKCB;ADCY3;CALM2;ADCY7;MAPK1;MMP14
128,prerank,RNA polymerase,-0.38939457337586303,-1.3102702746223152,0.10638297872340426,0.3311042805100182,0.97,16/30,38.22%,POLR1E;POLR2I;POLR3K;POLR3GL;POLR2G;POLR2L;POLR2J3;POLR1C;POLR3E;POLR2J2;POLR2H;POLR3H;POLR2C;POLR2F;POLR1D;POLR2D
129,prerank,Glutamatergic synapse,0.427711638006223,1.3102539024855038,0.13214739517153748,0.21298424460379492,1.0,18/48,22.58%,GNB4;GNG10;GLS;PLA2G4A;GLUL;GNAQ;SLC38A2;PPP3R1;GRK3;GNAI3;ITPR2;GNB1;GNG5;PRKCB;GNB2;ADCY3;ADCY7;MAPK1
130,prerank,Nicotinate and nicotinamide metabolism,0.4912674107275388,1.308873773962852,0.13733905579399142,0.21340114993365766,1.0,4/23,5.26%,NADK;CD38;NT5C2;NAMPT
131,prerank,Malaria,0.4601518230882914,1.3073434843565086,0.13850415512465375,0.21393616869498225,1.0,10/32,10.68%,ICAM1;CCL2;IL1B;TLR2;CD36;CD40;TLR4;TNF;MYD88;TGFB1
132,prerank,Breast cancer,0.3956120752454746,1.3054566523443951,0.10869565217391304,0.21471915081822202,1.0,35/74,26.85%,GADD45B;TCF7L2;RB1;BAK1;NOTCH2;SOS1;SP1;NOTCH1;NCOA1;CDKN1A;FZD2;PTEN;GSK3B;GRB2;NCOA3;CSNK1A1;APC;NFKB2;KRAS;PIK3CA;POLK;NRAS;RAF1;SOS2;IGF1R;E2F2;FRAT2;FRAT1;MAPK1;CDK6;BRAF;FZD1;SHC1;PIK3CB;TCF7L1
133,prerank,Apelin signaling pathway,0.3920602823941498,1.3035702826797262,0.08558030480656506,0.2156388871338009,1.0,36/86,28.52%,GNB4;ACTA2;GNG10;HDAC4;GNA13;GNAQ;SLC8A1;SPHK1;MEF2A;TGFBR1;GNAI3;ITPR2;PRKAG2;KRAS;GABARAP;PIK3CG;GNB1;NRAS;BECN1;PIK3R5;MEF2C;RAF1;GNG5;CALML4;GNB2;ADCY3;CALM2;ADCY7;MAPK1;GABARAPL2;TFAM;PRKAA1;PRKAG1;HDAC5;RPS6KB1;SMAD4
134,prerank,Arginine and proline metabolism,0.4552825864468166,1.2916804783953142,0.1532033426183844,0.2311795003952679,1.0,3/30,2.10%,LAP3;SAT1;CNDP2
135,prerank,Sphingolipid signaling pathway,0.37626419253198745,1.28893498843083,0.09860788863109049,0.23339023109243698,1.0,38/95,23.31%,GNA13;TNFRSF1A;TNF;MAPK14;SPTLC2;PPP2R2A;BID;S1PR3;GNAQ;FCER1G;SPHK1;PTEN;GAB2;MAP3K5;DEGS1;ROCK1;RAC1;GNAI3;KRAS;PPP2R5B;PIK3CA;NFKB1;SPTLC1;S1PR2;ASAH1;ROCK2;PPP2CB;NRAS;PPP2CA;RAF1;PDPK1;PRKCB;PPP2R3C;RHOA;SGMS1;PPP2R5C;MAPK1;CERS6
136,prerank,Small cell lung cancer,0.39497770725249115,1.2862875544878578,0.11467324290998766,0.2355066873750724,1.0,18/62,19.94%,GADD45B;PTGS2;RB1;BAK1;XIAP;CDKN1A;MAX;PTEN;NFKBIA;CHUK;APAF1;BIRC2;PIK3CA;NFKB1;POLK;CASP3;TRAF6;E2F2
137,prerank,Long-term depression,0.44629795945684725,1.285108837205044,0.15595075239398085,0.235413193617528,1.0,13/33,19.91%,LYN;GNA13;PLA2G4A;GNAQ;GNAI3;ITPR2;KRAS;PPP2CB;NRAS;PPP2CA;RAF1;IGF1R;PRKCB
138,prerank,Natural killer cell mediated cytotoxicity,0.3782245916303418,1.2827894363610202,0.09038238702201622,0.23704298915226998,1.0,37/92,19.91%,TNFSF10;FAS;ICAM1;MICB;LCP2;FCGR3B;FCGR3A;PAK1;TNF;IFNAR2;HLA-G;HLA-C;SOS1;IFNAR1;SH3BP2;PTK2B;HLA-E;BID;HLA-B;FCER1G;MICA;IFNGR2;PTPN6;GRB2;HLA-A;PPP3R1;RAC1;KRAS;PIK3CA;TYROBP;NRAS;RAF1;SOS2;CASP3;TNFRSF10B;SYK;PRKCB
139,prerank,Pancreatic secretion,0.4262541204599929,1.2794753086336577,0.16233766233766234,0.23997996327717688,1.0,16/41,21.93%,CTRL;CD38;ATP1B3;CA2;GNAQ;RAB8A;RAC1;ITPR2;ATP2A2;RAB11A;RAP1A;RAB3D;PRKCB;ADCY3;RHOA;ADCY7
140,prerank,Fc epsilon RI signaling pathway,0.3994243427236387,1.270705376719657,0.13513513513513514,0.2515188901045182,1.0,23/53,26.34%,LYN;LCP2;TNF;PLA2G4A;MAPK14;SOS1;FCER1G;GAB2;GRB2;RAC1;KRAS;MAP2K4;PIK3CA;NRAS;RAF1;SOS2;PDPK1;SYK;VAV1;MAPK1;ALOX5;PIK3CB;BTK
141,prerank,Insulin resistance,0.37630426128280187,1.253124368112985,0.1332547169811321,0.2777218507198637,1.0,37/80,29.85%,STAT3;SOCS3;CD36;CREB5;TNFRSF1A;TNF;SLC27A3;PRKCD;PTPN1;PPP1R3B;PTEN;GSK3B;NFKBIA;CREB1;PRKAG2;CPT1B;PIK3CA;NFKB1;RPS6KA3;PPP1CB;CREB3L2;PDPK1;PRKCB;PPP1R3D;PTPN11;INSR;PRKAA1;PIK3CB;PRKAG1;PPP1CC;RELA;PTPA;RPS6KB1;OGA;PCK2;PYGL;RPS6KA1
142,prerank,Colorectal cancer,0.3808740989397883,1.2525283175078468,0.14302884615384615,0.2765164545350304,1.0,22/74,18.30%,GADD45B;RALB;TCF7L2;BAK1;SOS1;CDKN1A;GSK3B;GRB2;PMAIP1;TGFB1;APC;RAC1;TGFBR1;KRAS;PIK3CA;TGFBR2;POLK;NRAS;RAF1;BCL2L11;SOS2;CASP3
143,prerank,Renin secretion,0.44968277693031006,1.2507468252084264,0.18723404255319148,0.27728002965892234,1.0,8/29,13.93%,KCNJ2;GNAQ;PTGER4;PPP3R1;CREB1;CTSB;GNAI3;ITPR2
144,prerank,Gastric cancer,0.3778344716749177,1.2471608806780674,0.16148325358851676,0.28105095284368065,1.0,37/75,30.51%,GADD45B;TCF7L2;RB1;BAK1;SOS1;CTNNA1;CDKN1A;FZD2;GSK3B;GRB2;TGFB1;CSNK1A1;APC;TGFBR1;KRAS;PIK3CA;TGFBR2;POLK;NRAS;RAF1;SOS2;E2F2;FRAT2;FRAT1;MAPK1;BRAF;FZD1;SHC1;PIK3CB;TCF7L1;CTNNB1;RPS6KB1;SMAD4;RXRA;CDKN1B;E2F3;GADD45G
145,prerank,ErbB signaling pathway,0.3839385743446014,1.2416507309753881,0.1771995043370508,0.2879962053471274,1.0,24/60,26.14%,SRC;STAT5A;PAK1;SOS1;CBL;CAMK2D;CDKN1A;PAK2;GSK3B;GRB2;CRK;KRAS;MAP2K4;PIK3CA;NRAS;RAF1;SOS2;PRKCB;STAT5B;MAPK1;CRKL;BRAF;SHC1;PIK3CB
146,prerank,Tight junction,0.36574955589045927,1.2411251434519204,0.13083048919226395,0.28677544474813776,1.0,40/98,26.38%,SRC;ARHGAP17;PPP2R2A;ACTR2;TJP2;RAB8B;WAS;VASP;ACTR3;ARPC5;F11R;RAP2C;RAB8A;MAP3K5;ARPC3;ACTN1;ROCK1;RAC1;PRKAG2;TUBA1A;RAPGEF2;CDC42;ACTB;ROCK2;PPP2CB;MAP3K1;CD1D;RAP1A;RUNX1;PPP2CA;ARHGEF2;RHOA;ACTN4;MSN;HSPA4;RDX;TUBA1B;TUBA1C;PRKAA1;PRKAG1
147,prerank,Mitophagy,0.39023521526011495,1.2342617939355733,0.18895705521472392,0.2958867757629367,1.0,18/62,17.93%,CALCOCO2;USP15;SRC;TBK1;RHOT1;SP1;HIF1A;USP30;TAX1BP1;NBR1;TFE3;KRAS;BNIP3L;USP8;GABARAP;NRAS;BECN1;RAB7A
148,prerank,Vibrio cholerae infection,0.41138172169466836,1.2299492296894496,0.1906005221932115,0.3012616020652382,1.0,14/40,21.90%,ATP6V1B2;ATP6V1G1;TJP2;ATP6V1A;ATP6V0D1;TCIRG1;ACTB;ATP6V1C1;ATP6V1E1;ATP6V1D;ADCY3;ATP6V0A1;ATP6V1C2;ARF1
149,prerank,Endometrial cancer,0.3933979073684055,1.2293827840015448,0.17780580075662042,0.30000436052849605,1.0,18/51,19.73%,GADD45B;TCF7L2;BAK1;SOS1;ILK;CTNNA1;CDKN1A;PTEN;GSK3B;GRB2;APC;KRAS;PIK3CA;POLK;NRAS;RAF1;SOS2;PDPK1
150,prerank,p53 signaling pathway,0.38858641257868953,1.229321745640233,0.1712846347607053,0.29799148220200855,1.0,11/54,13.03%,FAS;GADD45B;SHISA5;RRM2B;BID;CDKN1A;COP1;PTEN;PMAIP1;MDM2;APAF1
151,prerank,AMPK signaling pathway,0.35809634905972404,1.2218315588757909,0.17592592592592593,0.3085762813897489,1.0,38/88,29.14%,CD36;CREB5;PPP2R2A;TBC1D1;RAB14;PFKFB4;RAB10;RAB8A;CREB1;RAB2A;PRKAG2;CPT1B;PPP2R5B;PFKFB2;PIK3CA;PPP2CB;PPP2CA;IGF1R;CREB3L2;PDPK1;CAB39;PPP2R3C;SIRT1;PPP2R5C;CAMKK2;PPP2R5E;INSR;PRKAA1;PIK3CB;PRKAG1;FOXO3;SCD;PPP2R5A;ADIPOR2;PFKP;RPS6KB1;MAP3K7;PCK2
152,prerank,Insulin signaling pathway,0.3486889425759666,1.217107914964655,0.15765765765765766,0.3143558693894981,1.0,41/108,26.51%,SOCS1;SOCS3;RHOQ;PRKAR1A;SOS1;CBL;SH2B2;PTPN1;PPP1R3B;GSK3B;GRB2;PRKAR2B;HK1;CRK;PRKAG2;KRAS;PIK3CA;PHKB;NRAS;RAF1;FLOT1;SOS2;SOCS4;PPP1CB;PDPK1;CALML4;PPP1R3D;INPPL1;HK2;CALM2;MAPK1;HK3;EIF4E2;CRKL;INSR;PRKAA1;BRAF;SHC1;PIK3CB;PRKAG1;PPP1CC
153,prerank,Prostate cancer,0.3687263716512944,1.2154153974455055,0.18078381795195955,0.31469437089904456,1.0,26/72,19.94%,TCF7L2;CREB5;RB1;SOS1;EP300;CREBBP;CDKN1A;PTEN;GSK3B;NFKBIA;GRB2;CREB1;CHUK;MDM2;KRAS;HSP90AA1;PIK3CA;NFKB1;NRAS;RAF1;SOS2;NKX3-1;IGF1R;CREB3L2;PDPK1;E2F2
154,prerank,Sphingolipid metabolism,0.4208950979757118,1.213058476640772,0.20502645502645503,0.3166304115631215,1.0,13/32,23.31%,GALC;SPTLC2;KDSR;SPHK1;DEGS1;ACER3;GLA;PSAP;SPTLC1;ASAH1;GLB1;SGMS1;CERS6
155,prerank,Oocyte meiosis,0.3624769873087808,1.2098733560735928,0.17119244391971664,0.3199448342637197,1.0,37/85,31.61%,SLK;CUL1;CPEB4;MAPK14;REC8;CAMK2D;PPP3R1;CPEB2;ITPR2;YWHAG;PPP2R5B;YWHAB;PPP2CB;CDC27;PPP2CA;YWHAE;RPS6KA3;IGF1R;PPP1CB;CALML4;ADCY3;CALM2;ADCY7;FBXW11;PPP2R5C;MAPK1;YWHAZ;PPP2R5E;SMC1A;PPP1CC;ANAPC13;PPP2R5A;RPS6KA1;CDC25C;YWHAH;PPP3CA;ITPR1
156,prerank,Signaling pathways regulating pluripotency of stem cells,0.3705693213396354,1.2082240262589192,0.1814903846153846,0.32073620688119825,1.0,21/66,19.30%,JAK2;STAT3;PCGF5;MAPK14;JAK3;KLF4;SKIL;FZD2;GSK3B;GRB2;APC;BMPR2;RIF1;KAT6A;SETDB1;KRAS;JARID2;PIK3CA;NRAS;RAF1;IGF1R
157,prerank,Serotonergic synapse,0.3886573026634388,1.2030807845852434,0.22704081632653061,0.32714875423853756,1.0,19/46,26.58%,GNB4;GNG10;PTGS2;PLA2G4A;GNAQ;GNAI3;ITPR2;KRAS;GNB1;NRAS;RAF1;CASP3;GNG5;PRKCB;GNB2;MAPK1;ALOX5;BRAF;DUSP1
158,prerank,Gap junction,0.3852903599688016,1.1992618500966072,0.22559366754617413,0.3318654056254778,1.0,21/48,26.77%,SRC;SOS1;GNAQ;GRB2;LPAR1;GNAI3;ITPR2;KRAS;TUBA1A;TUBB1;NRAS;RAF1;SOS2;MAP3K2;PRKCB;ADCY3;ADCY7;MAPK1;TUBA1B;TUBA1C;GNA11
159,prerank,Melanoma,0.3948798522780872,1.1943679514815053,0.23803009575923392,0.3386222910216718,1.0,17/40,26.14%,GADD45B;RB1;BAK1;CDKN1A;PTEN;MDM2;KRAS;PIK3CA;POLK;NRAS;RAF1;IGF1R;E2F2;MAPK1;CDK6;BRAF;PIK3CB
160,prerank,PI3K-Akt signaling pathway,0.32754012646901753,1.1869981604262159,0.1723404255319149,0.3494607337258949,1.0,58/184,21.08%,JAK2;PIK3AP1;GNB4;GNG10;TLR2;CREB5;TLR4;PKN2;IFNAR2;MCL1;SOS1;IFNAR1;JAK3;IL6R;PPP2R2A;PHLPP1;CSF1;CDKN1A;ITGA4;PTEN;GSK3B;CSF3R;GRB2;CREB1;LPAR6;CHUK;OSM;LPAR1;MDM2;RAC1;ATF2;YWHAG;KRAS;PPP2R5B;HSP90AA1;YWHAB;PIK3CA;ITGB3;NFKB1;LPAR2;PIK3CG;GNB1;PPP2CB;NRAS;PIK3R5;PPP2CA;YWHAE;RAF1;BCL2L11;SOS2;GNG5;IGF1R;CREB3L2;PDPK1;SYK;GNB2;PPP2R3C;SGK3
161,prerank,beta-Alanine metabolism,0.4539029682567263,1.1866970408969542,0.26308139534883723,0.3476869216586156,1.0,4/20,16.37%,CNDP2;DPYD;ACOX1;ALDH2
162,prerank,Neuroactive ligand-receptor interaction,0.36243212730226226,1.1800468298992937,0.21237864077669902,0.3570572541410452,1.0,19/69,17.18%,P2RY14;CHRNB2;P2RX7;P2RY13;ADM;F2RL1;FPR2;C3AR1;S1PR3;PTGER4;PTAFR;LPAR6;LPAR1;CYSLTR1;FPR1;NR3C1;LPAR2;CYSLTR2;S1PR2
163,prerank,Ras signaling pathway,0.33397524422183716,1.1796495788402075,0.18888888888888888,0.3554488597058256,1.0,44/127,21.50%,GNB4;RALB;GNG10;TBK1;PAK1;PLA2G4A;SHOC2;SOS1;RAB5A;CSF1;REL;PAK2;GAB2;RAB5C;GRB2;CHUK;RASSF5;RAC1;NF1;KRAS;PIK3CA;KSR1;CDC42;NFKB1;RASGRP4;RASGRP3;GNB1;NRAS;ETS2;RAP1A;RAF1;SOS2;RALBP1;ARF6;GNG5;IGF1R;BRAP;CALML4;PRKCB;GNB2;STK4;CALM2;RHOA;PTPN11
164,prerank,cGMP-PKG signaling pathway,0.349335501182446,1.1780085239519815,0.22520420070011668,0.3562132194480206,1.0,31/89,22.58%,CREB5;GNA13;ATP1B3;GNAQ;VASP;SLC8A1;PPIF;PPP1R12A;MEF2A;PPP3R1;CREB1;ROCK1;GNAI3;ITPR2;ATF2;ATP2A2;PIK3CG;ROCK2;PIK3R5;MEF2C;RAF1;PPP1CB;CREB3L2;CALML4;SRF;ADCY3;CALM2;RHOA;KCNMB1;ADCY7;MAPK1
165,prerank,Oxytocin signaling pathway,0.3527917014359844,1.1760168674795832,0.22860492379835873,0.35777968749125233,1.0,31/90,22.58%,KCNJ2;PTGS2;SRC;CD38;PLA2G4A;GNAQ;CAMK2D;CDKN1A;PPP1R12A;PPP3R1;CAMK1D;ROCK1;GNAI3;ITPR2;PRKAG2;KRAS;PIK3CG;ACTB;ROCK2;NRAS;PIK3R5;MEF2C;RAF1;PPP1CB;CALML4;PRKCB;ADCY3;CALM2;RHOA;ADCY7;MAPK1
166,prerank,Long-term potentiation,0.3926738647057948,1.175037752909778,0.2513440860215054,0.35724716897682607,1.0,22/42,31.61%,GNAQ;CAMK2D;EP300;CREBBP;PPP3R1;ITPR2;KRAS;NRAS;RAP1A;RAF1;RPS6KA3;PPP1CB;CALML4;PRKCB;CALM2;MAPK1;BRAF;PPP1CC;RAP1B;RPS6KA1;PPP3CA;ITPR1
167,prerank,Circadian entrainment,0.3929183591206939,1.1699785274075358,0.2444733420026008,0.3642124613003096,1.0,17/41,22.58%,GNB4;GNG10;GNAQ;CAMK2D;CREB1;GNAI3;RPS6KA5;GNB1;GNG5;CALML4;PRKCB;GNB2;ADCY3;CALM2;PER2;ADCY7;MAPK1
168,prerank,Metabolism of xenobiotics by cytochrome P450,-0.38388861462400287,-1.169934034672195,0.23548387096774193,0.6576442015786278,1.0,9/19,19.01%,GSTM2;AKR7A2;EPHX1;GSTM1;GSTM4;GSTP1;MGST3;CBR3;CYP2D6
169,prerank,Phospholipase D signaling pathway,0.3468256024891291,1.1689262686614676,0.21107266435986158,0.3638457671398079,1.0,33/91,22.58%,RALB;GNA13;AGPAT3;PLA2G4A;CYTH4;SOS1;PTK2B;FCER1G;SPHK1;GAB2;GRB2;CXCR2;LPAR6;LPAR1;PIP5K1A;KRAS;PIK3CA;LPAR2;CXCR1;PIK3CG;AGPAT5;NRAS;PIK3R5;RAF1;SOS2;ARF6;SYK;ADCY3;RHOA;PTPN11;ARF1;ADCY7;MAPK1
170,prerank,Olfactory transduction,0.42961035625391086,1.1522242144746568,0.29772079772079774,0.3929622531273718,1.0,8/22,21.39%,CAMK2D;ARRB2;SLC8A1;GRK3;GNB1;CALML4;ADCY3;CALM2
171,prerank,Hepatocellular carcinoma,0.330990011818067,1.1492377498012152,0.23990772779700115,0.39595108304865373,1.0,45/108,28.67%,GADD45B;TCF7L2;RB1;BAK1;GSTO1;SOS1;NFE2L2;CDKN1A;FZD2;PTEN;GSK3B;GRB2;SMARCD3;TGFB1;ARID1A;CSNK1A1;APC;TGFBR1;KRAS;PIK3CA;TGFBR2;POLK;ACTB;NRAS;RAF1;SOS2;IGF1R;PRKCB;E2F2;PBRM1;FRAT2;FRAT1;MAPK1;BRD7;CDK6;ARID1B;BRAF;FZD1;SHC1;PIK3CB;TCF7L1;CTNNB1;RPS6KB1;SMAD4;ARID2
172,prerank,Thyroid cancer,0.39915226427205835,1.1490926187275328,0.29333333333333333,0.39375923668568835,1.0,17/30,30.51%,GADD45B;TCF7L2;BAK1;CDKN1A;TFG;NCOA4;KRAS;POLK;NRAS;TPM3;MAPK1;BRAF;TCF7L1;TPR;CTNNB1;RXRA;GADD45G
173,prerank,Hedgehog signaling pathway,0.4061348651140195,1.140353717044903,0.29388297872340424,0.40765684264136276,1.0,20/31,35.86%,CUL1;SPOPL;ARRB2;GSK3B;CSNK1A1;GRK3;CUL3;CSNK1G1;FBXW11;GLI1;IQCE;SMURF1;CSNK1G2;CSNK1D;SPOP;MGRN1;PRKACA;CSNK1G3;GRK2;SMURF2
174,prerank,Central carbon metabolism in cancer,0.362859324307973,1.1382474757087975,0.27989821882951654,0.409031082312443,1.0,17/52,23.77%,SCO2;GLS;HIF1A;PTEN;IDH1;SLC1A5;HK1;SLC16A3;KRAS;PIK3CA;NRAS;RAF1;TIGAR;HK2;PDK1;MAPK1;HK3
175,prerank,Inositol phosphate metabolism,0.3575972406926169,1.1335357930129544,0.2881773399014778,0.4154737848495843,1.0,28/58,30.76%,ITPK1;IPMK;PTEN;FIG4;PI4K2B;MTMR6;MTMR4;PIKFYVE;CDIPT;PIP5K1A;SYNJ1;MTMR3;PIK3CA;IMPA1;PIK3CG;MTM1;PIK3C2A;INPPL1;INPP1;MTMR14;SACM1L;MTMR1;PIK3CB;MINPP1;PI4KB;SYNJ2;PIP4K2C;PIK3C3
176,prerank,Oxidative phosphorylation,-0.24917672426561788,-1.1324071613510813,0.12941176470588237,0.7200018214936248,1.0,52/117,32.73%,ATP6V0E2;COX3;CYTB;NDUFV1;COX2;ND2;NDUFB9;ATP5MC2;ATP5F1D;NDUFB11;ND4;NDUFS8;ND1;NDUFB7;ATP8;COX1;ND3;COX4I1;ATP6;ND6;NDUFS3;ATP5MC1;NDUFB8;UQCRH;NDUFS5;ND5;ATP5PD;NDUFB10;NDUFA13;ATP5MG;COX11;LHPP;COX7A2L;NDUFA11;UQCR11;NDUFC1;NDUFA3;NDUFS7;COX7C;NDUFA4;ND4L;UQCR10;ATP6V1E2;NDUFA7;COX10;NDUFB4;ATP5ME;UQCRHL;NDUFA6;COX6C;COX6B1;NDUFA10
177,prerank,Vascular smooth muscle contraction,0.3483719948536371,1.1293921933283158,0.2991556091676719,0.42101709104694507,1.0,21/62,22.58%,ACTA2;ADM;GNA13;PLA2G4A;GNAQ;PRKCD;PPP1R12A;ROCK1;ITPR2;ARHGEF11;ROCK2;RAF1;PPP1CB;CALML4;PRKCB;ADCY3;CALM2;RHOA;KCNMB1;ADCY7;MAPK1
178,prerank,Vasopressin-regulated water reabsorption,0.393615220620829,1.1273474194233204,0.32038834951456313,0.4224121912857326,1.0,14/32,28.60%,CREB5;RAB5A;RAB5C;CREB1;DYNC1LI1;RAB11A;DCTN4;CREB3L2;NSF;ADCY3;DYNC1LI2;DCTN6;STX4;RAB5B
179,prerank,Inflammatory mediator regulation of TRP channels,0.3470020048747866,1.10985247396621,0.30778739184178,0.4537164711085672,1.0,18/57,21.93%,IL1B;SRC;F2RL1;IL1RAP;PLA2G4A;MAPK14;GNAQ;CAMK2D;PRKCD;PTGER4;ITPR2;PIK3CA;PPP1CB;CALML4;PRKCB;ADCY3;CALM2;ADCY7
180,prerank,Pathways of neurodegeneration,0.29582841950933625,1.1081133854193705,0.23225152129817445,0.45458719037014617,1.0,88/345,23.39%,UBE2L6;FAS;LRRK2;CYBB;CASP7;IL1B;PSMA4;PTGS2;TANK;TBK1;PSMB3;KIF5B;BAK1;PSMA3;TNFRSF1A;TNF;ATF6;ATG2A;UBE2J1;MAPK14;RAB5A;BID;NRBF2;GNAQ;CAMK2D;NDUFB6;RAB1A;CSF1;CHMP2B;RB1CC1;FZD2;PSEN1;GSK3B;PPIF;PSEN2;FIG4;CSNK1A1;RAB8A;APC;MAP3K5;PPP3R1;SPG11;NDUFB3;HSPA5;PSMB2;PSMA5;DERL1;APAF1;RAC1;ITPR2;TNFRSF1B;DNAH17;PSMB4;KRAS;TUBA1A;TUBB1;ATP2A2;NFKB1;CASP8;GABARAP;PSMA2;MCU;NRAS;BECN1;PSMA6;WDR41;RAF1;CASP3;UBA7;DCTN4;SDHD;UBA1;CALML4;PRKCB;PSMD3;NDUFA9;CALM2;ATXN1;FRAT2;PSMD12;PSMA1;FRAT1;PSMB1;MAPK1;SQSTM1;ACTR10;SMCR8;EIF2S1
181,prerank,"Glycine, serine and threonine metabolism",-0.36024564514735574,-1.092413449622991,0.2980132450331126,0.8087514489153833,1.0,7/19,23.33%,GAMT;AMT;GLYCTK;SHMT2;GNMT;SHMT1;GRHPR
182,prerank,Focal adhesion,0.31674983633894976,1.0916201346732648,0.32045454545454544,0.4851154047910474,1.0,43/107,28.09%,SRC;PAK1;XIAP;SOS1;ILK;VASP;PAK2;TLN1;ITGA4;PTEN;GSK3B;GRB2;PPP1R12A;PIP5K1A;ACTN1;ROCK1;RAC1;BIRC2;CRK;PIK3CA;ITGB3;CDC42;ACTB;ROCK2;RAP1A;RAF1;SOS2;IGF1R;PPP1CB;PDPK1;PRKCB;VAV1;RHOA;ACTN4;MAPK1;CRKL;BRAF;SHC1;PIK3CB;PPP1CC;MYL12A;PXN;CTNNB1
183,prerank,Thyroid hormone synthesis,0.36727104389889403,1.0875826881726927,0.363395225464191,0.4908820845040176,1.0,15/40,23.37%,CREB5;ATP1B3;ASGR2;GNAQ;CREB1;HSPA5;ITPR2;ATF2;GSR;CREB3L2;PRKCB;ADCY3;ADCY7;HSP90B1;ASGR1
184,prerank,Basal transcription factors,0.37246087837449615,1.0873901016158583,0.35602094240837695,0.4885438749002323,1.0,23/37,38.28%,GTF2B;GTF2H2;GTF2H2C;TAF10;GTF2A1;TAF13;TAF8;TAF1;GTF2E1;TAF7;GTF2E2;TBPL1;GTF2I;GTF2H1;CDK7;TAF12;TAF2;TAF5;TAF15;CCNH;GTF2F2;TAF4B;TAF3
185,prerank,HIF-1 signaling pathway,0.324536547323755,1.084747142960049,0.3478787878787879,0.4914449990522525,1.0,30/80,28.41%,CYBB;STAT3;EGLN1;LTBR;TLR4;IL6R;HIF1A;CAMK2D;EP300;CREBBP;CDKN1A;IFNGR2;HK1;PIK3CA;NFKB1;IGF1R;PRKCB;HK2;CUL2;PDK1;MAPK1;PGK1;HK3;EIF4E2;INSR;PIK3CB;IFNGR1;RELA;PFKP;RPS6KB1
186,prerank,Base excision repair,-0.30836241578200163,-1.072684237838987,0.3527272727272727,0.8197024893746206,1.0,19/31,29.44%,NTHL1;POLD2;LIG1;APEX1;MPG;UNG;NEIL2;MUTYH;PARP2;NEIL1;POLD1;PCNA;POLE;PARP1;POLE3;XRCC1;POLL;OGG1;HMGB1
187,prerank,mTOR signaling pathway,0.31155561799481657,1.0699902912067807,0.3367003367003367,0.5190407502714005,1.0,39/110,26.14%,RICTOR;LPIN2;ATP6V1B2;TNFRSF1A;TNF;SOS1;ATP6V1G1;ATP6V1A;FZD2;PTEN;GSK3B;GRB2;RRAGC;CHUK;FNIP1;CLIP1;KRAS;PIK3CA;NRAS;RAF1;SOS2;ATP6V1C1;LAMTOR3;RPS6KA3;ATP6V1E1;IGF1R;PDPK1;PRKCB;CAB39;ATP6V1D;RHOA;ATP6V1C2;MAPK1;EIF4E2;INSR;PRKAA1;BRAF;FZD1;PIK3CB
188,prerank,Fructose and mannose metabolism,-0.30723495485497815,-1.0698315502639084,0.33840304182509506,0.7680720190556256,1.0,8/29,15.38%,AKR1B1;MPI;PMM1;ALDOC;PMM2;KHK;FCSK;ENOSF1
189,prerank,Peroxisome,0.333057080493,1.0658967529265744,0.3637469586374696,0.5245666509244198,1.0,9/61,11.81%,SOD2;ACSL4;FAR2;ACSL1;ACSL5;GSTK1;FAR1;IDH1;ABCD1
190,prerank,Glycerolipid metabolism,0.3661330691182149,1.0608741120030354,0.4007884362680683,0.5322108145446233,1.0,9/36,18.83%,GK;LPIN2;MBOAT2;AGPAT3;GLA;MBOAT1;ALDH2;AGPAT5;AKR1A1
191,prerank,Glycosphingolipid biosynthesis,0.39038844864226924,1.059500266053313,0.37980085348506404,0.5323199553270294,1.0,9/24,19.80%,ST3GAL5;B3GNT5;FUT4;GLA;NAGA;ST3GAL6;B3GNT2;GLB1;ST3GAL2
192,prerank,"Alanine, aspartate and glutamate metabolism",0.40931519387382587,1.0593676556287102,0.3990895295902883,0.5296943338739004,1.0,3/18,7.75%,GLS;IL4I1;GLUL
193,prerank,Glycerophospholipid metabolism,0.32447887295871736,1.0567713424879415,0.3637440758293839,0.5322536109529593,1.0,15/66,17.00%,LPCAT2;LPIN2;GPD2;MBOAT2;MBOAT7;AGPAT3;PLA2G4A;LPGAT1;LYPLA1;CDS2;PISD;CDIPT;MBOAT1;PGS1;AGPAT5
194,prerank,Melanogenesis,0.343416303552579,1.0563824870604304,0.38992042440318303,0.5302465115600896,1.0,19/49,22.58%,TCF7L2;GNAQ;CAMK2D;EP300;CREBBP;FZD2;GSK3B;CREB1;GNAI3;KRAS;NRAS;RAF1;CREB3L2;CALML4;PRKCB;ADCY3;CALM2;ADCY7;MAPK1
195,prerank,Adrenergic signaling in cardiomyocytes,0.3195359071415541,1.0548506180788169,0.39927623642943305,0.5307809059775765,1.0,27/80,22.58%,CREB5;ATP1B3;MAPK14;PPP2R2A;GNAQ;CAMK2D;SLC8A1;CREB1;GNAI3;ATF2;PPP2R5B;ATP2A2;PIK3CG;RPS6KA5;PPP2CB;PIK3R5;PPP2CA;PPP1CB;CREB3L2;CALML4;ADCY3;PPP2R3C;TPM3;CALM2;ADCY7;PPP2R5C;MAPK1
196,prerank,Mineral absorption,0.3725532091304857,1.0491018844528026,0.40329218106995884,0.5399147645328154,1.0,9/30,18.63%,MT2A;ATP1B3;SLC31A1;VDR;SLC8A1;SLC30A1;SLC40A1;ATP7A;ATOX1
197,prerank,Alzheimer disease,0.2765356899342088,1.0266010496246785,0.43149284253578735,0.5834658187599364,1.0,86/278,28.23%,FAS;EIF2AK2;CYBB;CASP7;IL1B;PSMA4;PTGS2;PSENEN;PSMB3;KIF5B;PSMA3;TNFRSF1A;TNF;ATF6;ATG2A;BID;NRBF2;GNAQ;RTN4;NDUFB6;CSF1;RB1CC1;FZD2;PSEN1;GSK3B;PPIF;PSEN2;NCSTN;CSNK1A1;APC;MAP3K5;PPP3R1;CHUK;NDUFB3;PSMB2;PSMA5;APAF1;ITPR2;ADAM10;PSMB4;KRAS;ADAM17;TUBA1A;TUBB1;PIK3CA;ATP2A2;NFKB1;CASP8;PSMA2;MCU;NRAS;BECN1;PSMA6;RAF1;CASP3;SDHD;CALML4;PSMD3;NDUFA9;CALM2;FRAT2;PSMD12;PSMA1;FRAT1;PSMB1;MAPK1;EIF2S1;TUBA1B;LRP1;TUBA1C;IDE;INSR;BRAF;FZD1;PSMD4;PIK3CB;AMBRA1;PSMD6;COX7B;RELA;PPID;ATP5F1E;APH1A;SDHB;CTNNB1;RTN3
198,prerank,Glycosaminoglycan degradation,0.42178454644082247,1.0206299677578705,0.4327666151468315,0.5928959019940744,1.0,3/15,8.39%,GNS;HPSE;ARSB
199,prerank,Citrate cycle (TCA cycle),0.36868992491928565,1.0179953322045683,0.438375350140056,0.5949227425279147,1.0,12/26,35.90%,ACO1;IDH1;SDHD;IDH3A;ACLY;IDH2;SDHB;DLD;PCK2;SDHA;OGDH;SDHC
200,prerank,Basal cell carcinoma,0.36743715661583104,1.0178252470862383,0.45006839945280436,0.5921934843366238,1.0,7/29,11.20%,GADD45B;TCF7L2;BAK1;CDKN1A;FZD2;GSK3B;APC
201,prerank,Lysine degradation,0.3365112199051139,1.014627193282721,0.4445893089960887,0.5958582263314682,1.0,12/44,20.41%,DHTKD1;TMLHE;SETD2;KMT2D;SETD7;SETDB1;KMT2C;KMT2E;ALDH2;SETD1B;KMT2B;ASH1L
202,prerank,Amino sugar and nucleotide sugar metabolism,-0.2714865418008971,-1.014338584197027,0.4557522123893805,0.9316939890710383,1.0,15/42,26.86%,AMDHD2;MPI;PMM1;CYB5R1;PGM1;PMM2;FCSK;UXS1;GPI;GALT;GNPDA1;HKDC1;UAP1;HEXA;GALK1
203,prerank,Porphyrin and chlorophyll metabolism,-0.3184742789185625,-1.0074056683956438,0.436046511627907,0.8968731026108075,1.0,12/21,33.09%,HMOX2;PPOX;FXN;HMBS;UROS;UROD;GUSB;ALAD;MMAB;COX10;BLVRB;EPRS1
204,prerank,Drug metabolism,0.32948601965691504,1.0049488425965987,0.47853535353535354,0.6126830233478433,1.0,7/46,10.47%,TYMP;DPYD;GSTO1;RRM2B;CES1;GSTK1;TPMT
205,prerank,Mismatch repair,-0.3289726548544051,-1.0047780407648104,0.4166666666666667,0.8508413023679418,1.0,12/20,38.47%,POLD2;LIG1;RPA1;RFC4;POLD1;PCNA;RPA2;PMS2;RFC2;POLD4;MSH2;MLH3
206,prerank,ECM-receptor interaction,-0.29124296725771437,-0.9977460856572281,0.449438202247191,0.8281613629058182,1.0,5/27,12.92%,COL6A2;THBS1;COL9A3;SPP1;COL6A1
207,prerank,Primary immunodeficiency,0.34570400407610996,0.9957423687833485,0.47733333333333333,0.6290711379619359,1.0,6/33,6.98%,TAP2;TAP1;CD40;CIITA;PTPRC;JAK3
208,prerank,Cushing syndrome,0.29797241604980995,0.9942408018479187,0.4658536585365854,0.6291636720477665,1.0,32/82,26.85%,TCF7L2;CREB5;RB1;SP1;GNAQ;CAMK2D;CDKN1A;LDLR;FZD2;GSK3B;KMT2D;APC;CREB1;GNAI3;ITPR2;ATF2;NCEH1;USP8;RAP1A;RBBP5;CREB3L2;E2F2;ADCY3;ADCY7;AHR;MAPK1;ASH2L;CDK6;BRAF;FZD1;GNA11;TCF7L1
209,prerank,Longevity regulating pathway,0.29952833019487707,0.992383869012539,0.49287410926365793,0.6297192997733589,1.0,28/79,28.43%,SOD2;CREB5;HSPA6;RB1CC1;CREB1;PRKAG2;ATF2;KRAS;HSPA8;PIK3CA;NFKB1;NRAS;IGF1R;CREB3L2;ADCY3;SIRT1;ADCY7;CAMKK2;EIF4E2;INSR;PRKAA1;PIK3CB;PRKAG1;RELA;FOXO3;ADIPOR2;RPS6KB1;HSPA1B
210,prerank,Phosphatidylinositol signaling system,0.3039346595538912,0.9920379586815291,0.48333333333333334,0.6271572655106535,1.0,32/75,28.71%,ITPK1;IPMK;CDS2;PTEN;PI4K2B;MTMR6;MTMR4;PIKFYVE;CDIPT;PIP5K1A;PIP4P2;SYNJ1;ITPR2;MTMR3;PIK3CA;IMPA1;BPNT2;MTM1;CALML4;PRKCB;PIK3C2A;INPPL1;CALM2;IP6K1;INPP1;MTMR14;SACM1L;MTMR1;PIK3CB;PI4KB;PPIP5K2;SYNJ2
211,prerank,TGF-beta signaling pathway,0.3253491692197711,0.9882582552062844,0.4908376963350785,0.6315109039567244,1.0,14/46,17.99%,CUL1;TNF;SP1;EP300;CREBBP;TGFB1;BMPR2;ROCK1;TGFBR1;ZFYVE16;TGFBR2;TGIF2;PPP2CB;PPP2CA
212,prerank,Endocrine and other factor-regulated calcium reabsorption,0.3484729437104862,0.9758277282611814,0.49719101123595505,0.6539232234247082,1.0,7/29,19.91%,ATP1B3;VDR;GNAQ;SLC8A1;CLTC;RAB11A;PRKCB
213,prerank,Fatty acid degradation,0.3389027367242705,0.9727007938252554,0.5033738191632928,0.6569181239153423,1.0,8/31,20.51%,ACSL4;ACSL1;ACSL5;CPT1B;ACOX1;ALDH2;ACSL3;HADHB
214,prerank,Aldosterone synthesis and secretion,0.3141322399887919,0.9706414058067943,0.5118110236220472,0.6578723993584674,1.0,16/51,21.93%,CREB5;PRKD2;ATP1B3;GNAQ;CAMK2D;LDLR;CREB1;CAMK1D;ITPR2;ATF2;CREB3L2;CALML4;PRKCB;ADCY3;CALM2;ADCY7
215,prerank,Amphetamine addiction,0.33587508736419164,0.9697611911406667,0.5120643431635389,0.6562056189839067,1.0,11/35,21.91%,CREB5;CAMK2D;PPP3R1;CREB1;ATF2;PPP1CB;CREB3L2;CALML4;PRKCB;CALM2;SIRT1
216,prerank,Prion disease,0.26379760755303305,0.962816046132868,0.5778474399164054,0.6671550199026979,1.0,40/214,18.30%,CYBB;C1QB;NCF1;IL1B;PSMA4;C1QC;CREB5;HSPA6;PSMB3;KIF5B;PSMA3;TNF;MAPK14;NOTCH1;NCF2;NDUFB6;PRKCD;C1QA;GSK3B;PPIF;PPP3R1;CREB1;NDUFB3;HSPA5;PSMB2;PSMA5;APAF1;RAC1;ITPR2;PSMB4;ATF2;NCF4;TUBA1A;HSPA8;TUBB1;PIK3CA;PSMA2;MCU;PSMA6;CASP3
217,prerank,Glucagon signaling pathway,0.2899192640599177,0.9512808942102086,0.558926487747958,0.6877102765693865,1.0,20/74,21.91%,CREB5;GNAQ;CAMK2D;EP300;CREBBP;PPP3R1;CREB1;ITPR2;PRKAG2;ATF2;CPT1B;PPP4R3B;PHKB;PPP4R3A;CREB3L2;CALML4;SIK1;PPP4C;CALM2;SIRT1
218,prerank,Circadian rhythm,-0.288303156659368,-0.9438831472604565,0.5562700964630225,0.9779022465088039,1.0,6/23,15.17%,PER1;NR1D1;RORC;CSNK1E;TPTEP2-CSNK1E;CRY2
219,prerank,Hippo signaling pathway,0.2812725623602822,0.936714914534922,0.5673758865248227,0.7131416923204925,1.0,23/83,19.31%,TCF7L2;STK3;MOB1A;PAK1;PPP2R2A;CTNNA1;FZD2;GSK3B;TGFB1;LATS2;APC;BMPR2;TGFBR1;BIRC2;YWHAG;YWHAB;TGFBR2;ACTB;PPP2CB;PPP2CA;YWHAE;LATS1;PPP1CB
220,prerank,Non-alcoholic fatty liver disease,0.26520696638063096,0.9343689577308648,0.6191512513601741,0.7144218849064126,1.0,25/131,18.92%,FAS;CASP7;IL1B;SOCS3;TNFRSF1A;TNF;MAPK14;IL6R;BID;NDUFB6;GSK3B;TGFB1;MAP3K5;MAP3K11;NDUFB3;RAC1;ITCH;PRKAG2;PIK3CA;CDC42;NFKB1;CASP8;BCL2L11;CASP3;SDHD
221,prerank,Cortisol synthesis and secretion,0.33146622140168136,0.9315202552331557,0.5534950071326676,0.7166543087823365,1.0,11/31,21.93%,CREB5;SP1;GNAQ;LDLR;CREB1;ITPR2;ATF2;NCEH1;CREB3L2;ADCY3;ADCY7
222,prerank,VEGF signaling pathway,0.2950113392451135,0.925385615636036,0.5708812260536399,0.7249382423059083,1.0,13/48,19.91%,PTGS2;SRC;PLA2G4A;MAPK14;SPHK1;PPP3R1;RAC1;KRAS;PIK3CA;CDC42;NRAS;RAF1;PRKCB
223,prerank,Ether lipid metabolism,-0.2713772802753651,-0.9224814928566261,0.5547445255474452,1.0,1.0,7/28,9.03%,PAFAH1B3;PLA2G4B;PLB1;JMJD7-PLA2G4B;LPCAT4;PLA2G6;PLD4
224,prerank,Cell cycle,0.2706128780373357,0.914521219356254,0.6164229471316085,0.7425080405182002,1.0,32/93,31.27%,GADD45B;CUL1;RB1;STAG2;EP300;CREBBP;CDKN1A;GSK3B;TGFB1;MDM2;YWHAG;RAD21;YWHAB;CDC27;YWHAE;E2F2;YWHAZ;CDK6;ORC4;CDKN2D;STAG1;ATR;SMC1A;ANAPC13;SMAD4;CDKN1B;CDC25C;E2F3;GADD45G;YWHAH;PRKDC;CDK7
225,prerank,Choline metabolism in cancer,0.2749935738499406,0.8985268825137475,0.6513872135102533,0.7697739660318743,1.0,21/68,22.58%,PLA2G4A;SOS1;SP1;HIF1A;WAS;LYPLA1;SLC22A4;GRB2;SLC44A2;PIP5K1A;RAC1;SLC22A1;KRAS;PIK3CA;NRAS;RAF1;SOS2;PDPK1;PRKCB;PCYT1A;MAPK1
226,prerank,Fatty acid elongation,-0.2878220748774852,-0.8944026517833862,0.6242424242424243,1.0,1.0,6/20,14.49%,TECR;THEM4;PPT2;ACOT2;HADH;THEM5
227,prerank,Bile secretion,0.32006652292385096,0.8923503503888224,0.6082758620689656,0.7775182441397612,1.0,9/29,21.93%,ATP1B3;CA2;LDLR;AQP9;SLC51A;SLC22A1;NCEH1;ADCY3;ADCY7
228,prerank,Amyotrophic lateral sclerosis,0.23868751890903894,0.8871834186456319,0.7617107942973523,0.7836383105244112,1.0,53/290,18.92%,CASP1;PSMA4;TANK;TBK1;PSMB3;SETX;KIF5B;PSMA3;TNFRSF1A;TNF;ATF6;ATG2A;UBQLN2;MAPK14;RAB5A;NUP50;BID;NRBF2;NDUFB6;RAB1A;CHMP2B;NUP58;RB1CC1;FIG4;RAB8A;MAP3K5;PPP3R1;SPG11;NDUFB3;HSPA5;PSMB2;PSMA5;DERL1;APAF1;RAC1;NXT2;TNFRSF1B;DNAH17;PSMB4;NUP62;TUBA1A;TUBB1;NUP153;GABARAP;PSMA2;ACTB;MCU;BECN1;PSMA6;WDR41;CASP3;DCTN4;SDHD
229,prerank,mRNA surveillance pathway,0.262484256264339,0.8785730683045057,0.6821345707656613,0.7960342031549462,1.0,42/82,39.03%,PPP2R2A;SMG1;PAPOLA;PCF11;NXT2;PPP2R5B;PAPOLG;PPP2CB;PPP2CA;CLP1;UPF2;PPP1CB;UPF1;PPP2R3C;ETF1;PPP2R5C;CPSF2;PPP2R5E;CSTF2T;CASC3;PPP1CC;GSPT1;PPP2R5A;CSTF3;SAP18;GLE1;SMG7;CPSF7;SRRM1;NUDT21;EIF4A3;PABPC1L;NCBP1;RNGTT;SYMPK;PPP2R1B;CPSF3;MAGOH;CPSF6;HBS1L;RBM8A;FIP1L1
230,prerank,Galactose metabolism,0.3359126310376965,0.8757247121489238,0.6477611940298508,0.7975961649314254,1.0,9/23,23.77%,GALM;MGAM2;HK1;GLA;MGAM;GLB1;HK2;UGP2;HK3
231,prerank,Thermogenesis,-0.17535359019149482,-0.8518821211228571,0.8666666666666667,1.0,1.0,80/191,33.07%,RPS6;COX3;CYTB;NDUFV1;COX2;ND2;NDUFB9;ATP5MC2;ATP5F1D;NDUFB11;ND4;NDUFS8;SLC25A20;ND1;NDUFB7;HRAS;ATP8;COX1;CREB3L4;ND3;NDUFAF8;COX4I1;ATP6;ND6;MAPK13;NDUFS3;ATP5MC1;NDUFB8;UQCRH;NDUFS5;PRKACB;NDUFAF2;RPS6KB2;ND5;ATP5PD;NDUFB10;CPT1A;SLC25A29;NDUFA13;ATP5MG;MLST8;COX19;COX11;FGFR1;RPTOR;ACSL6;COX7A2L;NDUFA11;UQCR11;BMP8A;NDUFC1;NDUFA3;KDM1A;NDUFS7;COA3;COX7C;NDUFA4;ND4L;UQCR10;BMP8B;COX14;NDUFA7;LIPE;MAPK11;SMARCA4;COX10;NDUFB4;SMARCC2;NDUFAF3;ATP5ME;ADCY9;UQCRHL;SMARCB1;NDUFA6;COX6C;TSC1;COX6B1;NDUFA10;COA4;PNPLA2
232,prerank,Glutathione metabolism,0.2925755084779141,0.8513439682933232,0.6923076923076923,0.8383594252000701,1.0,5/36,11.21%,LAP3;GSTO1;RRM2B;GSTK1;IDH1
233,prerank,Carbohydrate digestion and absorption,0.3162951583684608,0.8502330434912023,0.6762589928057554,0.8364428054394479,1.0,9/25,26.14%,ATP1B3;MGAM2;HK1;PIK3CA;MGAM;PRKCB;HK2;HK3;PIK3CB
234,prerank,Cocaine addiction,0.32479102368210677,0.846813617391707,0.6754002911208151,0.8387344116200341,1.0,6/22,19.53%,CREB5;CREB1;GNAI3;ATF2;NFKB1;CREB3L2
235,prerank,Bladder cancer,0.2909043406007998,0.8401453986835701,0.6900826446280992,0.8464560854941732,1.0,10/32,19.94%,TYMP;SRC;RB1;CDKN1A;MDM2;KRAS;RPS6KA5;NRAS;RAF1;E2F2
236,prerank,Wnt signaling pathway,-0.19117813059195246,-0.8346679876445647,0.8428571428571429,1.0,1.0,23/88,19.24%,TCF7;SERPINF1;TLE2;LEF1;PORCN;MYC;CBY1;JUN;LGR6;CSNK1E;AXIN2;TLE1;CTNNBIP1;DVL1;TPTEP2-CSNK1E;PPARD;PRICKLE3;WNT10A;WNT10B;PRKACB;AXIN1;NFATC3;RUVBL1
237,prerank,Arrhythmogenic right ventricular cardiomyopathy,0.29435843608578044,0.8229017574502746,0.7184466019417476,0.8724834963225057,1.0,8/30,17.09%,TCF7L2;DSC2;CTNNA1;SLC8A1;ITGA4;ITGB3;ATP2A2;ACTB
238,prerank,Insulin secretion,0.28145357615849964,0.8210373111173925,0.7127799736495388,0.8716219934493322,1.0,11/35,21.93%,CREB5;ATP1B3;GNAQ;CAMK2D;CREB1;ATF2;CREB3L2;PRKCB;ADCY3;KCNMB1;ADCY7
239,prerank,Pentose phosphate pathway,-0.25218604620107044,-0.8178296818509666,0.7326388888888888,1.0,1.0,14/23,37.50%,TKTL1;PGM1;ALDOC;PRPS1;GLYCTK;GPI;PGLS;FBP1;PFKL;IDNK;PGM2;PFKM;ALDOA;RPIA
240,prerank,Hypertrophic cardiomyopathy,0.2847461064432715,0.8125383127329451,0.728882833787466,0.8816327110274337,1.0,9/34,17.09%,TNF;SLC8A1;ITGA4;TGFB1;MYBPC3;PRKAG2;ITGB3;ATP2A2;ACTB
241,prerank,Calcium signaling pathway,0.23728411237827265,0.810782854821818,0.798154555940023,0.8804495121768967,1.0,25/90,21.93%,P2RX7;CD38;PTK2B;GNAQ;CAMK2D;SLC8A1;PTAFR;SPHK1;PPIF;PPP3R1;CAMK1D;CYSLTR1;ITPR2;PHKB;ATP2A2;CYSLTR2;MCU;STIM2;CALML4;PRKCB;ADCY3;GNA15;CALM2;ORAI2;ADCY7
242,prerank,"Valine, leucine and isoleucine degradation",-0.219213186117912,-0.8068992546305208,0.7878787878787878,1.0,1.0,15/38,32.11%,IVD;BCAT2;ABAT;HADH;ACADS;ACAA2;HSD17B10;ACAD8;OXCT1;MCCC1;AACS;PCCB;BCKDHA;ACAA1;MCEE
243,prerank,Aldosterone-regulated sodium reabsorption,0.31407047948697864,0.8068814483422844,0.6856702619414484,0.8829309235655984,1.0,8/18,26.14%,ATP1B3;KRAS;PIK3CA;PDPK1;PRKCB;MAPK1;INSR;PIK3CB
244,prerank,Regulation of lipolysis in adipocytes,0.2810868756293397,0.8067430763343523,0.7323162274618585,0.8791258823129157,1.0,15/29,35.54%,PTGS2;GNAI3;PIK3CA;ADCY3;ADCY7;ABHD5;INSR;PIK3CB;PTGS1;PDE3B;GNAI2;PIK3CD;NPPA;PRKACA;ADCY4
245,prerank,Protein digestion and absorption,0.285919994678202,0.8008547858648098,0.739010989010989,0.884529487470664,1.0,8/29,15.24%,CTRL;ATP1B3;SLC38A2;SLC8A1;SLC7A7;SLC1A5;PRCP;KCNE3
246,prerank,Fanconi anemia pathway,0.2690885600624435,0.795004860731147,0.7601043024771839,0.8895375473767511,1.0,7/39,19.04%,RMI2;FANCL;FANCA;RMI1;USP1;POLK;ATRIP
247,prerank,Dilated cardiomyopathy,0.2703209281223547,0.7933688300052596,0.7315789473684211,0.8880048730018323,1.0,11/36,21.93%,TNF;SLC8A1;ITGA4;TGFB1;MYBPC3;ITGB3;ATP2A2;ACTB;ADCY3;TPM3;ADCY7
248,prerank,Starch and sucrose metabolism,0.304409334682561,0.7906329469939412,0.7474452554744525,0.8882795223352498,1.0,10/21,30.66%,MGAM2;HK1;MGAM;HK2;UGP2;HK3;GBE1;GYG1;PYGL;GANC
249,prerank,Steroid biosynthesis,-0.2726242854576493,-0.787494514414839,0.7727272727272727,1.0,1.0,4/16,19.30%,EBP;TM7SF2;LSS;DHCR7
250,prerank,T cell receptor signaling pathway,0.23448278621275137,0.7852107424558584,0.8302325581395349,0.8925684852422571,1.0,23/89,18.19%,LCP2;PTPRC;PAK1;TNF;MAPK14;SOS1;NFKBIE;PAK2;PTPN6;MAP3K8;GSK3B;NFKBIA;GRB2;PPP3R1;CHUK;BCL10;KRAS;PIK3CA;CDC42;NFKB1;NRAS;RAF1;SOS2
251,prerank,Propanoate metabolism,-0.22905475772266454,-0.7785772997793737,0.7876712328767124,1.0,1.0,4/27,14.16%,LDHB;ACACB;ABAT;ACADS
252,prerank,Biosynthesis of unsaturated fatty acids,0.30368060838747357,0.7746289174494152,0.7767584097859327,0.9046424041445931,1.0,4/18,16.37%,ELOVL5;ACOT7;ACOX1;HACD4
253,prerank,Ovarian steroidogenesis,0.2811495347053084,0.7574478475599842,0.7722063037249284,0.9247237676233928,1.0,9/23,25.76%,PTGS2;PLA2G4A;LDLR;IGF1R;ADCY3;CYP1B1;ADCY7;ALOX5;INSR
254,prerank,Aminoacyl-tRNA biosynthesis,0.23307146121673683,0.7452066304368213,0.8682926829268293,0.9373581655139647,1.0,2/66,4.24%,WARS1;KARS1
255,prerank,Salivary secretion,0.25307658833921676,0.7444968956415794,0.8253968253968254,0.9341864892410053,1.0,10/37,21.93%,CD38;ATP1B3;GNAQ;LYZ;ITPR2;CALML4;PRKCB;ADCY3;CALM2;ADCY7
256,prerank,Purine metabolism,0.22103149373995437,0.7376338347273184,0.8960573476702509,0.9394188297328501,1.0,9/79,11.32%,PDE4B;NT5C3A;NT5C2;RRM2B;NUDT16;ENTPD1;PRPS2;ADA2;PAPSS1
257,prerank,Other types of O-glycan biosynthesis,0.2663770441931122,0.7349983151398134,0.8333333333333334,0.9384627262883375,1.0,3/27,9.70%,GALNT3;C1GALT1;C1GALT1C1
258,prerank,Nucleotide excision repair,-0.1935100648808263,-0.7257902252325886,0.9174311926605505,1.0,1.0,19/40,36.26%,POLD2;LIG1;GTF2H4;RPA1;ERCC2;RFC4;ERCC1;ERCC3;POLD1;PCNA;POLE;POLE3;XPA;RPA2;DDB2;RFC2;ERCC5;BIVM-ERCC5;POLD4
259,prerank,Glyoxylate and dicarboxylate metabolism,-0.2166303557683392,-0.7129492612749582,0.8733333333333333,1.0,1.0,13/23,35.54%,AMT;PGP;GLYCTK;HYI;SHMT2;SHMT1;GRHPR;MDH2;PCCB;MDH1;MCEE;ACSS1;AFMID
260,prerank,Huntington disease,0.19136761623193965,0.7027929306148826,0.972972972972973,0.9718106804501786,1.0,36/244,18.92%,SOD2;TGM2;PSMA4;CREB5;PSMB3;KIF5B;PSMA3;ATG2A;SP1;RCOR1;NRBF2;GNAQ;EP300;NDUFB6;CREBBP;RB1CC1;PPIF;MAP3K5;CREB1;NDUFB3;PSMB2;PSMA5;APAF1;DNAH17;PSMB4;CLTC;POLR2A;TUBA1A;TUBB1;CASP8;PSMA2;BECN1;PSMA6;CASP3;DCTN4;SDHD
261,prerank,RNA degradation,0.21438724822189195,0.6964778854917439,0.936374549819928,0.9738855056192517,1.0,23/68,31.53%,XRN1;PATL1;NUDT16;DCP2;PNPT1;C1D;PAN3;DHX36;CNOT1;DCP1A;BTG2;CNOT3;CNOT4;TENT4B;CNOT6L;CNOT8;CNOT2;PFKP;DIS3;HSPD1;DDX6;XRN2;LSM8
262,prerank,One carbon pool by folate,0.28501563515503,0.6895966546180045,0.8513931888544891,0.976366134359679,1.0,1/15,2.44%,MTHFD2
263,prerank,Parkinson disease,0.18958074303405223,0.6888345129226179,0.9757127771911299,0.9730207872622734,1.0,37/206,22.50%,UBE2L6;LRRK2;PSMA4;PSMB3;KIF5B;PSMA3;ATF6;UBE2J1;NFE2L2;CAMK2D;NDUFB6;PPIF;MAP3K5;NDUFB3;HSPA5;PSMB2;PSMA5;APAF1;GNAI3;ITPR2;PSMB4;TUBA1A;TUBB1;PSMA2;MCU;PSMA6;CASP3;UBA7;SDHD;UBA1;CALML4;PSMD3;NDUFA9;CALM2;PSMD12;PSMA1;PSMB1
264,prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.24493380139403345,0.6777219139925356,0.8563458856345886,0.9790811727755726,1.0,2/23,10.11%,PIGF;PIGB
265,prerank,Progesterone-mediated oocyte maturation,0.20837047145666268,0.6751198591729073,0.9322033898305084,0.9773181718507836,1.0,27/65,35.82%,CPEB4;MAPK14;GNAI3;CPEB2;KRAS;HSP90AA1;PIK3CA;CDC27;RAF1;RPS6KA3;IGF1R;ADCY3;ADCY7;MAPK1;BRAF;PIK3CB;ANAPC13;RPS6KA1;STK10;CDC25C;PDE3B;GNAI2;CDC26;PIK3CD;PRKACA;ADCY4;MAPK8
266,prerank,GnRH secretion,0.2289994864504565,0.65799609544907,0.9080779944289693,0.9868397920718608,1.0,11/32,26.77%,GNAQ;ARRB2;ITPR2;KRAS;PIK3CA;NRAS;RAF1;PRKCB;MAPK1;PIK3CB;GNA11
267,prerank,Retrograde endocannabinoid signaling,0.1949869529282548,0.6553986557743088,0.9639115250291036,0.9846629441250185,1.0,17/85,22.58%,GNB4;GNG10;PTGS2;MAPK14;GNAQ;NDUFB6;NDUFB3;GNAI3;ITPR2;GNB1;GNG5;PRKCB;GNB2;ADCY3;NDUFA9;ADCY7;MAPK1
268,prerank,N-Glycan biosynthesis,-0.1651827294212673,-0.6255180540689441,1.0,1.0,1.0,20/41,38.09%,DPM3;MAN1B1;ALG1;B4GALT3;MAN1C1;MOGS;MGAT4B;DOLPP1;ALG12;ALG3;MGAT3;SRD5A3;MGAT4A;DDOST;ST6GAL1;DPM2;ALG2;ALG9;ALG5;DAD1
269,prerank,Homologous recombination,0.2230916996449696,0.6229771797063735,0.9427792915531336,1.0,1.0,3/28,14.11%,NBN;RBBP8;POLD3
270,prerank,Diabetic cardiomyopathy,0.17104431672624565,0.6075650891573577,0.9957173447537473,1.0,1.0,24/164,16.95%,CYBB;NCF1;CD36;MAPK14;SP1;NCF2;CAMK2D;NDUFB6;PRKCD;PDK3;PTEN;GSK3B;PPIF;TGFB1;NDUFB3;RAC1;TGFBR1;NCF4;CPT1B;PIK3CA;ATP2A2;NFKB1;TGFBR2;GSR
271,prerank,RNA transport,-0.12233015508315856,-0.5961248504435912,1.0,1.0,1.0,56/159,34.29%,EEF1A1;SNORD3A;PABPC4;RNU1-1;EIF3F;EIF4B;RNU1-3;RNU1-2;RNU1-4;RPP21;EIF3G;EIF3E;THOC3;NUP210;RNVU1-18;PABPC1;RPP25L;POP5;PYM1;GEMIN4;CYFIP2;PABPC3;NXT1;UPF3A;EIF3C;EIF3CL;EIF3D;RNU6-9;ELAC1;AAAS;EIF2B4;SNUPN;EIF2B3;EIF2B5;EIF3H;POP7;RAN;RNVU1-7;NUP35;EIF3I;POM121;NUP85;EIF3B;THOC1;POM121C;GEMIN6;RNPS1;NUP188;TACC3;GEMIN8;EIF2B1;DDX20;UBE2I;EIF4A2;NUP88;EIF2B2
272,prerank,Terpenoid backbone biosynthesis,0.22495526042928635,0.5828761078413522,0.9526542324246772,1.0,1.0,10/20,37.28%,ZMPSTE24;IDI1;FNTB;HMGCS1;NUS1;PDSS1;GGPS1;PDSS2;FNTA;ACAT2
273,prerank,Glycosaminoglycan biosynthesis,0.19724987339011119,0.5650980906278529,0.9667994687915007,1.0,1.0,12/35,26.05%,CHST15;CHSY1;DSE;EXT1;NDST1;B3GNT2;NDST2;ST3GAL2;CHST11;CHST7;CHPF2;HS2ST1
274,prerank,Other glycan degradation,-0.19071013845466725,-0.558854225550824,0.9787878787878788,0.9934426229508196,1.0,15/15,80.96%,ENGASE;HEXA;MAN2C1;NEU3;FUCA1;AGA;MAN2B1;MAN2B2;HEXB;MANBA;GBA2;NEU1;HEXD;FUCA2;GLB1
275,prerank,Glycolysis / Gluconeogenesis,0.18225390398634925,0.5545395638622811,0.9882198952879581,1.0,1.0,14/45,29.14%,GALM;ADPGK;HK1;ACSS2;ALDH2;BPGM;AKR1A1;HK2;PGK1;HK3;MINPP1;DLD;PFKP;PCK2
276,prerank,Protein export,0.20499678665117713,0.5360876712632314,0.9733520336605891,1.0,1.0,13/21,45.30%,HSPA5;SRP54;SRP19;SPCS3;SEC61A2;SEC11A;SRP9;SEC62;SRPRA;SEC61G;SEC63;SRP72;SPCS2
277,prerank,Cysteine and methionine metabolism,0.1811461140913166,0.5149268510251673,0.9838926174496644,1.0,1.0,4/33,14.92%,MAT2B;IL4I1;AMD1;AHCYL1
278,prerank,Spliceosome,0.14293935512378916,0.5037407853419155,1.0,1.0,1.0,45/139,32.37%,HSPA6;RNVU1-4;DHX8;PRPF40A;CRNKL1;TRA2A;SLU7;HSPA8;HNRNPK;SMNDC1;RBM25;SNRNP27;DHX15;RBMXL1;ISY1-RAB43;SF3B4;THOC2;CDC40;SF3B6;SF3B1;SYF2;SRSF4;SART1;SRSF1;AQR;RBM22;SRSF10;U2SURP;HNRNPU;HSPA1B;HNRNPA3;PCBP1;SNRPB2;DDX23;SNRPG;HSPA1A;CHERP;CDC5L;SNW1;SF3A1;RNU6-1;LSM8;HNRNPC;TRA2B;PRPF18
279,prerank,Various types of N-glycan biosynthesis,0.16468982047662933,0.4704989714607565,0.9918478260869565,1.0,1.0,5/31,23.17%,MAN1A1;MAN2A1;ALG11;HEXD;MGAT1
280,prerank,Pyruvate metabolism,0.14001274612660547,0.394432882691185,0.995768688293371,0.9997257850508624,1.0,4/28,18.83%,ME2;ACSS2;ALDH2;AKR1A1
